Test Menu Catalog

No matches found

• 1 1,25-Dihydroxyvitamin D
• 1 2Plex, IL-2, TNF-g
• 1 2Plex, IL-8, TNF-a
• 1 2Plex TCF4, CD123
• 1 3Plex CD8, CD3, FoxP3
• 1 4Plex CD4, GATA-3, CD3, FoxP3, calculation
• 1 4Plex OX40, OX40L, HLA-DR, CD3
• 1 5'-nucleotidase
• 1 5-hydroxyindoleacetic acid (5-HIAA), urine
• 1 6 Thioguamine Nucleotides & 6 Methylmercaptocurines Nucleotides
• 1 17-hydroxypregnenolone
• 1 17-hydroxyprogesterone (17-OHPC)
• 1 25-hydroxyvitamin D
• 2 40X Difficult tissue - with QC
• 2 40X Standard tissue - with QC
• 1 AAV9 Human IgG, ELISA, min batch size 25
• 1 ABCC4 [M4I-10]
• 1 Acetaminophen (paracetamol)
• 1 Acetylcholine Receptor Antibodies
• 1 Acetylcholinesterase
• 1 Acid-Fast Bacilli (AFB), direct examination
• 1 Acid Biles, Total
• 1 Acute myeloid leukemia (AML) broad panel NGS
• 1 Acute myeloid leukemia (AML) CD123 panel
• 1 Acute myeloid leukemia (AML) minimal residual disease (MRD) panel (AML MRD)
• 1 ADA Confirmation, batch size 40-250
• 1 ADA Confirmation, batch size >250
• 1 ADAMTS13 enzyme activity (a disintegrin and metalloproteinase with thrombospondin type 1 motif, member 13)
• 1 ADA Screening, batch size 40-250
• 1 ADA Screening, batch size 251-3000
• 1 ADA Screening, batch size >3000
• 1 ADA Titer, batch size >200
• 1 Additional data
• 1 Adenovirus, culture
• 1 Adenovirus, viral load
• 1 Adipophilin/CD138/CD45
• 1 Adipophilin [BSB-91]
• 1 Adrenocorticoid Hormone (ACTH)
• 1 Adrenocorticoid Hormone (ACTH), stimulation testing
• 1 Aiolos Ikaros and monocytes panel
• 1 Aiolos Ikaros panel
• 1 Alanine Aminotransferase, ALT (GPT, SGPT)
• 1 Albumin
• 1 Albumin / microalbumin, 24 hr urine
• 1 Alcohol, Ethanol
• 1 Alcohol, Ethanol, Urine
• 1 Aldolase
• 1 Aldosterone (supine)
• 2 Alizarin Red
• 1 Alkaline phosphatase (ALP)
• 1 Alkaline Phosphatase, Bone (BALP, BSAP, ostase)
• 1 ALK translocation, FISH
• 1 ALK [D5F3]
• 1 Allergir TAB
• 1 Alpha-1 fetoprotein (AFP)
• 1 Alpha-1 microglobulin
• 1 Alpha-1-antitrypsin
• 1 Alpha-1-antitrypsin (AATD) genotyping
• 1 Alpha-2 macroglobulin
• 1 ALPP
• 1 AMH [5/6]
• 1 Amikacin
• 1 Amino acid quantification
• 1 Amitryptyline
• 1 Ammonia (NH3)
• 1 Amphetamines
• 1 Amplification (protocol developed requiring an amplification)
• 1 Amylase
• 1 Androgen
• 1 Androstenedione
• 1 Angiotensin-converting Enzyme (ACE)
• 1 Angiotensine II
• 1 Animal tissue sourcing
• 1 Annexine 5 anti-IgG
• 1 Anti-beta2GP1 IgG
• 1 Anti-beta2GP1 IgM
• 1 Anti-Cardiolipin antibody, IgA, IgG, IgM
• 1 Anti-cyclic citrullinated peptide (CCP)
• 1 Anti-desmoglein 3
• 1 Anti-double stranded DNA (dsDNA Ab), qualitative
• 1 Anti-epithelial cell antibodies
• 1 Anti-gliadin IgG IgA
• 1 Anti-GM-CSF
• 1 Anti-ilots
• 1 Anti-insulin
• 1 Anti-myositis antibodies, complete panel (PL7,PL12,EJ,OJ,SRP,MI2,KU,PMSCL,JO1,TIF1 G,MDA5,NXP2,SAE)
• 1 Anti-Müllerian Hormone (AMH)
• 1 Anti-nuclear antibody (ANA)
• 1 Anti-nuclear antibody (ANA) - double stranded DNA (dsDNA Ab) (qualitative)
• 1 Anti-nuclear antibody (ANA) - ID CENP
• 1 Anti-nuclear antibody (ANA) - ID Jo-1
• 1 Anti-nuclear antibody (ANA) - ID Rib-P
• 1 Anti-nuclear antibody (ANA) - ID Scl-70s
• 1 Anti-nuclear antibody (ANA) - ID SmDp
• 1 Anti-nuclear antibody (ANA) - ID U1RNP (RNP A- C & 70)
• 1 Anti-nuclear antibody (ANA) connective tissue diseases (CTD) screen
• 1 Anti-nuclear antibody (ANA) pattern
• 1 Anti-nuclear antibody (ANA) titer
• 1 Anti-PLA2R antibodies testing (Phospholipase A2 receptor) - Dosage
• 1 Anti-PLA2R antibodies testing (Phospholipase A2 receptor) - Screening
• 1 Anti-platelets, Antibody
• 1 Anti-ribonuclear protein
• 1 Anti-smooth muscle antibody (ASMA)
• 1 Anti-streptolysin O (ASO)
• 1 Anti-tetanus antibody, IgG
• 1 Anti-thyroid peroxidase (anti-TPO) 
• 1 Anti-thyroid stimulating hormone receptor (Anti-TSHR)
• 1 Anti-transglutaminase IgA and IgM
• 1 Anti-VLP human IgG ELISA, min batch size 25
• 1 Anti-Xa activity
• 1 Antimicrobial antibodies (AMA) titer
• 1 Antimicrobial susceptibility testing (AST) anaerobes (E-test-MIC values, EUCAST guidelines)
• 1 Antineutrophil Cytoplasmic Antibodies (ANCA), Antibody (c-ANCA Ab)
• 1 Antineutrophil Cytoplasmic Antibodies (ANCA), Antibody (p-ANCA Ab)
• 1 Antineutrophil Cytoplasmic Antibodies (ANCA), ID PR3
• 1 Antineutrophil Cytoplasmic Antibodies (ANCA), Screen IFA
• 1 Antineutrophil Cytoplasmic Antibodies (ANCA), Titer  (ANCA titer)
• 1 Antithrombin IIa Activity via heparin cofactor II (HCII)
• 1 Antithrombin III activity
• 1 Apolipoprotein A1
• 1 Apolipoprotein B
• 1 Apolipoprotein E (ApoE) genotyping
• 1 Apolipoprotein Profile, calculation
• 1 Apoliprotein CIII
• 1 App development: Visiopharm
• 2 App Setting determination for Virtual Multiplex on Visiopharm
• 1 Arsenic
• 1 aSMA [1A4]
• 1 Aspartate Aminotransferase AST (GOT, SGOT)
• 1 Aspergillus fumigatus IgE (M3), Galactomannan Assay
• 1 Aspergillus IgG
• 1 Aspergillus PCR
• 1 Auromine stain of sputa for tuberculosis (TB)
• 1 AXL
• 1 Azan Mallory
• 1 b-type natriuretic peptide (BNP)
• 1 Bacteria, urine
• 1 Bacterial pneumonia multiplex FTD CAP 1 panel qPCR + Bacterial Bordetella species FTD qPCR - Batch size = 1
• 1 Bacterial pneumonia multiplex FTD CAP 1 panel qPCR + Bacterial Bordetella species FTD qPCR - Batch size = 2
• 1 Bacterial pneumonia multiplex FTD CAP 1 panel qPCR + Bacterial Bordetella species FTD qPCR - Batch size = 3
• 1 Bacterial pneumonia multiplex FTD CAP 1 panel qPCR + Bacterial Bordetella species FTD qPCR - Batch size = 4
• 1 Bacterial pneumonia multiplex FTD CAP 1 panel qPCR + Bacterial Bordetella species FTD qPCR - Batch size = 5
• 1 Bacterial pneumonia multiplex FTD CAP 1 panel qPCR + Bacterial Bordetella species FTD qPCR - Batch size = 6
• 1 Bacterial pneumonia multiplex FTD CAP 1 panel qPCR + Bacterial Bordetella species FTD qPCR - Batch size = 7
• 1 Bacterial pneumonia multiplex FTD CAP 1 panel qPCR + Bacterial Bordetella species FTD qPCR - Batch size = 8
• 1 Bacterial pneumonia multiplex FTD CAP 1 panel qPCR + Bacterial Bordetella species FTD qPCR - Batch size = 16
• 1 Bacterial pneumonia multiplex FTD CAP 1 panel qPCR + Bacterial Bordetella species FTD qPCR - Batch size = 22
• 1 Bacterial Vaginosis Panel (Candida species. and Trichomoniasis Vaginalis)
• 1 Barbiturates (phenobarbital)
• 1 Barbiturates, Urine
• 1 Basophil activation test (BAT), allergies
• 1 B cell, GPRC5D panel, bone marrow
• 1 B cell panel
• 1 B cells (% MNC)
• 1 B cells, monocytes and dentritic cells (DC) panel
• 1 BCMA, percent
• 1 BCMA/CXCR3/CD20/CD138/CD3
• 1 BCMA panel, bone marrow
• 1 Benzodiazepines, urine
• 1 Beryllium
• 1 Beta-2 glycoprotein IgG antibody
• 1 Beta-2 glycoprotein IgM antibody
• 1 Beta-2 microglobulin
• 1 Beta-2 Microglobulin, urine
• 1 Beta-Hydroxybutyrate (BOH)
• 1 Beta amyloid
• 1 Beta Carotene
• 1 Betacorona SARS Clade (E-gene), qPCR
• 1 Bicarbonate and total CO₂
• 1 Bilirubin
• 1 Bilirubin, direct
• 1 Bilirubin, indirect (calculation)
• 1 Bilirubin, total (=direct + indirect)
• 1 Biobanking management
• 1 Biobanking storage: FFPE block
• 1 Biobanking storage: FFPE slide
• 1 Biobanking storage: frozen bag 14''x20''
• 1 Biobanking storage: frozen block
• 1 Biobanking storage: frozen classic cryotubes box
• 1 Biobanking storage: frozen grand tubes box
• 1 Biobanking storage: frozen slide
• 1 Biochemistry panel
• 1 Biochemistry panel 1 analyte
• 1 Biochemistry panel 2-3 analytes
• 1 Biochemistry panel 2-4 analytes
• 1 Biochemistry panel 4-6 analytes
• 1 Biochemistry panel 5-6 analytes
• 2 Biochemistry panel 7-11 analytes
• 1 Biochemistry panel 7-12 analytes
• 1 Biochemistry panel 12-16 analytes
• 1 Biochemistry panel 13-20 analytes
• 1 Biochemistry panel 17-23 analytes
• 2 Biochemistry panel >16 analytes
• 1 Biochemistry panel >20 analytes
• 1 Biodistribution (segmentation and proximity)
• 1 Biofire Respiratory multiplex PCR
• 1 Biomarker singleplex, batch size 60-480
• 1 Biomarker singleplex, batch size >480
• 1 Biopsy processing (Tissue)
• 1 BK virus (human polyomavirus 1), viral load
• 1 Bleu Alcian/PAS
• 1 Bleu Alcian pH 1.0
• 1 Bleu Alcian pH2.5 congele
• 1 Blood culture
• 1 Blood urea nitrogen (BUN), serum
• 1 Blood urea nitrogen (BUN), urine
• 1 Blue Alcian pH2.5
• 1 Blue de Toluidine Resine
• 1 BNK panel, blood
• 1 Bodian
• 1 Bone Marrow Biopsy
• 1 Bone Marrow Biopsy (Block)
• 1 Bone Marrow Biopsy (Embedding)
• 1 Bone Marrow Plasmocyte Count
• 1 Bone marrow smear, interpretation
• 1 Borrelia (lyme disease) IgG
• 1 Borrelia (lyme disease) IgG, IgM
• 1 Borrelia (lyme disease) IgM
• 1 BRAF V600E
• 1 BRAF V600E mutation (ddPCR)
• 1 BRAF V600E [VE1]
• 1 BrdU [BU1/75]
• 2 Bright field 20X – Difficult tissue - with QC
• 2 Bright field 20X – Standard tissue - with QC
• 1 Bright field 20X – tumor microarray (TMA) - with QC
• 1 BSL-3 culturing viruses
• 1 Buprenorphine (BUP)
• 2 c-Met
• 1 c-MYC
• 1 C-Peptide
• 1 C-reactive protein (CRP)
• 1 C-reactive protein, high sensitive (hs-CRP)
• 1 C1 Complement, Esterase Inhibitor
• 1 Caffeine
• 1 CAIX [EP161]
• 1 Calcitonin
• 1 Calcium
• 1 Calcium, ionized
• 1 Calcium, urine random
• 1 Calprotectin, stool
• 1 Cancer Antigen 15-3 (CA 15-3)
• 1 Cancer Antigen 19-9 (CA 19-9)
• 1 Cancer Antigen 27-29 (CA 27-29)
• 1 Cancer Antigen 72-4 (CA 72-4)
• 1 Cancer Antigen 125 (CA 125)
• 1 Carbamazepine
• 1 Carbohydrate-deficient transferrin (CDT) 
• 1 Carboxyhemoglobin
• 1 Carcino-embryonic antigen (CEA)
• 1 Cardiolipin, IgA
• 1 Cardiolipin, IgG
• 1 Cardiolipin, IgM
• 1 CAR impuritiy panel
• 1 CAR T panel
• 1 CAR T panel, blood
• 1 CAR T panel, bone marrow
• 1 CAR T panel, cerebrospinal fluid (CSF)
• 1 CAR T panel, percent
• 1 Casts
• 1 Cat dander (e1)
• 1 CC-10
• 1 CCR8
• 1 CCR8/TNFR2
• 1 CD3
• 1 CD3 /CD16/CD56
• 1 CD3 [2GV6]
• 1 CD3 [SP7]
• 1 CD3+ purity
• 1 CD3/CD8/FoxP3
• 1 CD3/CD8/FoxP3/EP4R/PanCK
• 1 CD3/CD11b/CD47/SIRPa
• 1 CD3/FoxP3
• 1 CD4 Count
• 1 CD4 [23]
• 1 CD4 [RPA-T4]
• 1 CD4 [SP355]
• 1 CD4/GATA-3/CD3/FoxP3
• 2 CD8
• 1 CD8 [4B11]
• 1 CD8 [C8/144B]
• 1 CD8 [RPA-T8]
• 1 CD8 [SP57]
• 1 CD8/CD39
• 1 CD11B [EPR1344]
• 1 CD16 [EPR16784]
• 2 CD19
• 1 CD19 [BT51E]
• 1 CD19+ purity
• 1 CD20
• 1 CD20 [L26]
• 1 CD20, secondary/CLIA
• 1 CD20/XBP1s
• 1 CD22 [E7L6Z]
• 1 CD22+ purity
• 1 CD25 [4C9]
• 1 CD30
• 1 CD30 [Ber-H2]
• 1 CD31
• 1 CD31 [EPR17259]
• 1 CD33 EMR2 panel, blood (tube 1 only)
• 1 CD33 EMR2 panel, bone marrow (tube 1 only)
• 1 CD33 EMR2 panel, bone marrow (tube 2 only)
• 1 CD34+ panel
• 1 CD34+ purity
• 1 CD38 Count
• 1 CD38 [SP149]
• 1 CD39 [EPR20627]
• 1 CD40 receptor occupancy (RO), CD40 RO B cells
• 1 CD44 [SP37]
• 1 CD45
• 1 CD45 [D9M8I]
• 1 CD45RO [UCHL1]
• 1 CD47 [D307P]
• 1 CD47 [SP279]
• 1 CD52
• 1 CD52 [YTH34.5]
• 1 CD56 [MRQ-42]
• 1 CD66B+ purity
• 1 CD68 [KP1]
• 1 CD68+ (cell density)
• 1 CD68/CD163
• 1 CD68/CD163/PD-L1/EP4R/PanCK
• 1 CD68/PD-L1/PanCK
• 1 CD80 / CD86 panel
• 1 CD99 [O13]
• 1 CD123 [BR4MS]
• 1 CD138 [B-A38]
• 1 CD138+
• 1 CD138+ purity
• 1 CD138- purity
• 1 CD155 [D8A5G]
• 1 CD163
• 1 CD163 [EDHu-1]
• 1 CD163 [EPR19518]
• 1 Cell Count, Cerebrospinal fluid (CSF)
• 1 Cell culture maintenance or re-start (per week) (no reagents included)
• 1 Celluar density
• 2 Cellular density by HALO Software (adding app development)
• 2 Cellular density by VISIOPHARM Software (adding app development)
• 1 Cerebrospinal fluid (CSF) properties
• 1 Ceruloplasmin
• 1 Chagas Antibody, Trypanosomiasis
• 1 Chikungunya virus antibody, IgG
• 1 Chikungunya virus antibody , IgG and IgM
• 1 Chikungunya virus antibody, IgM
• 1 Chikungunya virus RNA screen, qualitative
• 1 Chlamydia, vaginalis, PCR
• 1 Chlamydia Pneumoniae, DNA screen
• 1 Chlamydia Pneumoniae antibody, IgA
• 1 Chlamydia Pneumoniae antibody, IgG (EIA)
• 1 Chlamydia Pneumoniae antibody, IgG (IFI)
• 1 Chlamydia Pneumoniae antibody, IgM
• 1 Chlamydia Psittaci antibody, IgA
• 1 Chlamydia Psittaci antibody, IgA, IgM, IgG, Immunofluorescence
• 1 Chlamydia Psittaci antibody, IgM
• 1 Chlamydia Psittaci IgG
• 1 Chlamydia trachomatis, PCR
• 1 Chlamydia Trachomatis antibody, IgA
• 1 Chlamydia Trachomatis antibody, IgG
• 1 Chlamydia Trachomatis IgM
• 1 Chloride (Cl), serum
• 1 Chloride (Cl), urine
• 1 Cholesterol, total
• 1 Cholinesterase
• 1 CHRM1 C267A genotyping
• 1 Chromogranin A (CgA)
• 1 Chromotrope Aniline Blue (CAB)
• 1 Circulating immune complex (CIC)
• 2 CISH Labelling
• 1 Citrate
• 1 Citrate, urine
• 1 Citrulline
• 1 CK8/CK18
• 1 CK16
• 1 CK16 [EP297]
• 1 Clarity, urine
• 1 Claudin18
• 1 Cleaved Caspase 3
• 1 Clobazam
• 1 Clostridium Difficile (C Diff), cytotoxin B with seroneutralization (tox B test)
• 1 Clostridium difficile (C Diff) toxin detection, PCR, stool
• 1 Clostridium difficile Ag (C Diff)
• 1 Clostridium difficile culture (C Diff)
• 1 Clostridium difficile toxin (C Diff)
• 1 Clostridium difficile toxin A/B (C Diff)
• 1 cMet [SP44]
• 1 CNND1/IGH
• 2 Co-expression by HALO Software (adding app development)
• 2 Co-expression by VISIOPHARM Software (per co-expression) (adding app development)
• 1 Cocaine, urine
• 1 Cockroach - German (i6)
• 1 Coenzyme Q10 (CoQ10)
• 1 Cold auto/allo antibodies
• 1 Collagen I
• 1 Collagen III
• 1 Collagen Type C-Telopeptide (CTx), CTx
• 1 Collagen Type III C-Telopeptide (CTx), CTx-III
• 1 Collagen VII [LH7.2]
• 1 Colloidal Iron
• 1 Color, urine
• 1 Complement 1Q (C1Q)
• 1 Complementary DNA (cDNA) sequencing, RNA virus stock, batch size 2-5 
• 1 Complementary DNA (cDNA) sequencing, RNA virus stock, batch size 6-10 
• 1 Complementary DNA (cDNA) sequencing, RNA virus stock, batch size 11-24
• 1 Complement C3
• 1 Complement C3, C4
• 1 Complement C4
• 1 Complement C5
• 1 Complement CH50 (total hemolytic complement)
• 1 Connexin 43
• 1 Coombs direct (direct antiglobulin)
• 1 Coombs indirect (indirect antiglobulin)
• 1 Copper
• 1 Cortisol (random)
• 1 Cortisol, plasma
• 1 Cortisol, saliva
• 1 Cortisol binding globulin (CBG)
• 1 Cortisol total, 24h urine
• 1 Cotinine, serum
• 1 Cotinine, urine
• 1 Creatine kinase (CK, CPK, creatine phosphokinase), total
• 1 Creatinine (24h), urine
• 1 Creatinine (enzymatic)
• 1 Creatinine, serum
• 1 Creatinine kinase-MB (CK-MB mass, macro creatinine kinase)
• 1 Creatinine kinase isoenzymes (CK isoenzymes)
• 1 Cryoglobulin
• 1 Crystals, urine
• 1 CTLA-4 [CAL49]
• 1 Culture result, stool
• 1 Culturing Influenza, embryonated chicken eggs
• 1 Culturing influenza, MDCK cell lines in flasks (from clinical samples)
• 1 Culturing influenza, MDCK cell lines in flasks (influenza reference strains)
• 1 Culturing Influenza, swab material in MDCK cell lines, min batch size 50
• 1 Culturing respiratory syncytial virus (RSV) in flaks
• 1 Culturing rhinovirus and enterovirus (EV), focused on EV, swab
• 1 Culturing rhinovirus and enterovirus (EV), focused on rhinovirus, swab
• 1 CXCL12 [79018]
• 1 Cyclosporin
• 1 Cyfra 21-1 (cytokeratin 19 fragment)
• 1 CYP2C9
• 1 CYP2C19
• 1 CYP2D6
• 1 CYP3A5
• 1 Cystatin C (IFCC)
• 1 Cytology, urine
• 1 Cytomegalovirus (CMV), viral load
• 1 Cytomegalovirus (CMV) antibody, IgG
• 1 Cytomegalovirus (CMV) antibody, IgM
• 1 Cytomegalovirus (CMV) gB viral protein, min batch size 25
• 1 Cytomegalovirus (CMV) gB viral protein, non specific, min batch size 25
• 1 Cytomegalovirus (CMV) gB viral protein avidity, min batch size 25
• 1 Cytomegalovirus (CMV) IgG and IgM
• 1 Cytomegalovirus (CMV) neutralization assay
• 1 Cytomegalovirus (CMV) pentamer, min batch size 25
• 1 Cytomegalovirus (CMV) pentamer avidity, min batch size 25
• 1 Cytomegalovirus (CMV DNA), PCR
• 1 Cytosol antibodies (LC1)
• 1 D-Dimer
• 1 D-Dimer, quantitative
• 1 D-Dimer, with controls
• 1 Dehydroepiandrosterone (DHEA)
• 1 Dehydroepiandrosterone Sulfate (DHEA-S)
• 2 Delineation, by a pathologist
• 2 Delineation, by a scientist
• 1 Dengue fever (DENV) qualitative detection (no calibration curves), batch size 11-21
• 1 Dengue fever (DENV) qualitative detection (no calibration curves), batch size 22-65
• 1 Dengue fever (DENV) qualitative detection (no calibration curves), batch size <11
• 1 Dengue fever (DENV) qualitative detection (no calibration curves), batch size >66
• 1 Dengue fever (DENV) quantification, serotype confirmation (incl. 4 calibration series), batch size 11-21
• 1 Dengue fever (DENV) quantification, serotype confirmation (incl. 4 calibration series), batch size 21-44
• 1 Dengue fever (DENV) quantification, serotype confirmation (incl. 4 calibration series), batch size <11
• 1 Dengue fever (DENV) quantification, serotype confirmation (incl. 4 calibration series), batch size >44
• 1 Dengue fever (DENV) whole genome sequencing (2 pools of non-overlapping fragments), batch 11-21
• 1 Dengue fever (DENV) whole genome sequencing (2 pools of non-overlapping fragments), batch <11
• 1 Dengue fever (DENV) whole genome sequencing (2 pools of non-overlapping fragments), batch >21
• 1 Dengue fever antibody, IgG, IgM
• 1 Dengue fever antibody, IgG, quantitative
• 1 Dengue fever antibody, IgM
• 1 Dengue fever genome screen, PCR
• 1 Dengue fever NS1 antigen
• 1 Dermatophagoides farinae (d2), house dust mite IgE
• 1 Dermatophagoides pterony (d1), house dust mite IgE
• 1 Differential count (complete blood count (CBC))
• 1 Differential count (complete blood count (CBC)) + reticulocytes (Ret)
• 1 Digital analysis rate per hour
• 1 Digoxin
• 1 Dihydropyrimidine dehydrogenase (DPD) genotyping
• 1 Dihydropyrimidine dehydrogenase (DPD) phenotyping
• 1 Dihydrotestosterone
• 1 Diphteria Antibodies
• 1 Direct RNA sequencing, RNA virus stock
• 1 DLL3 [E3J5R]
• 1 DLL3 [SP347]
• 1 DNA Flexigene, QIaGen
• 1 DNA preparation (FFPE) extraction, purification and quantification
• 1 DNA sequencing, DNA virus stock, batch size 1
• 1 DNA sequencing, DNA virus stock, batch size 2-5
• 1 DNA sequencing, DNA virus stock, batch size 6-10
• 1 DNA sequencing, DNA virus stock, batch size 11-24
• 1 DNA Storage
• 1 Dog dander (e5)
• 1 Dog hair (epithelia/dander) specific IgE (e2)
• 1 Drug Abuse or Screen, Urine, 1 Parameter
• 1 Drug Abuse or Screen, Urine, 1+ Parameters
• 1 Drug Abuse or Screen, Urine, 3 Parameters
• 1 Drug Abuse or Screen, Urine, 5 Parameters
• 1 Drug Abuse or Screen, Urine, 6 Parameters
• 1 Drug Abuse or Screen, Urine, 7 Parameters
• 1 Drug Abuse or Screen, Urine, 8 Parameters
• 1 Drug Abuse or Screen, Urine, 9 Parameters
• 1 Drug Abuse or Screen, Urine, 10 Parameters
• 1 Drug Abuse or Screen, Urine, 11 Parameters
• 1 Drug Abuse or Screen, Urine, Extra Parameters
• 1 Dual DNA/RNA preparation (FFPE) extraction, purification and quantification
• 1 Dyhydrotestosterone (DHT)
• 1 E-Cadherin [24E10]
• 1 Echovirus 7 neutralization assay, min batch size 35
• 1 EDTA tube processing
• 1 EGFR
• 1 EGFR Rapid (42 variant/PCR)
• 1 EGFR T790M
• 1 EGFR [3C6]
• 1 EGFR [EP38Y]
• 1 EGRF, ALK, ROS1 genes
• 1 Elastase
• 1 Elastin/Vimentin
• 1 Elastin [10B8]
• 1 ELISA, background measured per sample
• 1 ELISA, one background measurement per plate, respiratory syncytial virus F aspect (RSV-F)
• 1 ELISA, one background measurement per plate, respiratory syncytial virus G protein (RSV-G)
• 1 ELISA, one background measurement per plate, respiratory syncytial virus preF aspect (RSV-preF)
• 1 Enhanced liver fibrosis (ELF) panel
• 1 Entamoeba Histolytica antibody, stool
• 1 Enterovirus (EV), full-length sequencing (Sanger), min batch size 10
• 1 Enterovirus (EV), qPCR
• 1 Enterovirus (EV), whole genome amplification (WGA), NGS, min batch size 12
• 1 Enterovirus D68 (EV-D68)
• 1 Eosinophil cationic protein (ECP)
• 1 EP4R
• 1 EP4R/Cox2/mPGES-1/PanCK
• 1 EpCAM [D9S3P]
• 1 Epstein-Barr virus (EBV) EBNA-1 IgG, qualitative
• 1 Epstein-Barr virus (EBV) EBNA IgG, quantitative
• 1 Epstein-Barr virus (EBV) IgM
• 1 Epstein-Barr virus (EBV) VCA IgG
• 1 Epstein-Barr virus (EBV) VCA IgG, quantitative
• 1 Epstein-Barr virus (EBV) VCA IgM
• 1 Epstein-Barr virus (EBV) VCA IgM, quantitative
• 1 Epstein-Barr virus (EBV DNA)
• 1 Epstein Barr Virus (EBV) viral load, PCR
• 1 Erythrocyte sedimentation rate (ESR)
• 1 Erythrocyte sedimentation rate (ESR), Westerngreen
• 1 Erythropoietin (EPO)
• 1 ER [SP1]
• 1 Estimated glomerular filtration rate (eGFR)
• 1 Estradiol (E2)
• 1 Estradiol (E2), men, children
• 1 Estradiol (E2), women
• 1 Estriol (E3)
• 1 Estrogen receptor (ER)
• 1 Estrone (E1)
• 1 Ethambutol
• 1 Ethionamide
• 1 Ethosuximide
• 1 Everolimus
• 1 Extractable nuclear antigen (ENA or RNP Ab)
• 1 Eye Culture
• 1 Facteur VIII (Von Willebrand)
• 1 Factor II activity
• 1 Factor IX
• 1 Factor IX (Gene F9) Sequencing
• 1 Factor IX, Activity
• 1 Factor IX, Inhibition Antibody
• 1 Factor IX, Screening
• 1 Factor V activity (Dahlback)
• 1 Factor VII activity
• 1 Factor VIII (Genotyping)
• 1 Factor VIII (Von Willebrand), Antibody
• 1 Factor VIII (Von Willebrand), Antigen
• 1 Factor VIIIc activity
• 1 Factor V Leiden, mutation
• 1 Factor X activity
• 1 Faeces aerobic culture
• 1 Faeces aerobic culture and susc. testing
• 1 Faeces parasites (mature and ova)
• 1 FAP
• 1 Fecal fat test
• 1 Ferritin
• 1 FFPE section curls in tube: 5 curls (5µm) & DNA decontamination
• 1 FFPE sections
• 1 FFPE sections: RNAse free
• 1 FFPE sections on megablock
• 1 FGFR3
• 1 FGFR3 [C51F2]
• 1 Fibrine, Monomer
• 1 Fibrinogen
• 1 Fibroblast growth factor 23 (FGF23)
• 1 Fibronectin
• 1 Filaggrin (FLG)
• 1 Filamentous fungi culture
• 1 Filamentous fungi identification
• 1 FISH 1q21 (amp/gain)
• 1 FISH del(17p13)
• 1 FISH del13
• 1 FISH HER2 status, FFPE
• 2 FISH Labelling
• 1 FISH t(4;14)
• 1 FISH t(14;16)
• 1 FISH v4
• 1 FISH v5
• 1 FISH v6
• 1 FISH v9
• 1 FLT3-NPM
• 1 FMR1 (X Fragile)
• 1 Folic acid (vitamin B9, folate)
• 1 Follicle Stimulating Hormone (FSH)
• 1 FoxA3
• 1 FoxP3 [236A/E7]
• 1 FoxP3 [mAbcam22510]
• 1 Free fatty acids (FFA, NEFA), stool
• 2 Frozen Sections
• 1 Frozen tissue slide sourcing without cession (6µm)
• 1 Fructosamine
• 1 Fungal susceptibility
• 1 Fungus culture
• 1 Gallyas
• 1 Gamma-delta T cell panel, blood (tube 1 only)
• 1 Gamma-delta T cell panel, bone marrow (tube 1 only)
• 1 Gamma-glutamyl transferase (GGT)
• 1 Gastrin
• 1 GCKR
• 1 Geboes score (Block)
• 1 Geboes score (L colon)
• 1 Geboes score (R colon)
• 1 Geboes score (Rectum)
• 1 Geboes score (Slides)
• 1 Geboes score (T colon)
• 1 Geboes score (Tissue)
• 1 General NGS sequeancing step, Illumina (including library preparation), min batch size 12
• 1 General virus, ViroSpot assay for phenotypic virus titration, min batch size 25
• 1 General virus, virus stock generation in cell culture
• 1 GeneXpert Ultra
• 1 Genital culture (bacteria/yeasts) + identification of isolated pathogens (cfr. Routine - Safety)
• 1 Genotyping with ultrasensitive Sanger Full length Gene Sequencing, Min batch size 10
• 1 Giardia lamblia and Cryptosporidium antigen
• 2 Giemsa
• 1 Giemsa stain
• 1 Giemsa stain, smear
• 1 GI PCR Panel, Stool
• 1 Glucagon
• 1 Glucose, cerebrospinal fluid (CSF)
• 1 Glucose, Fasting
• 1 Glucose, plasma
• 1 Glucose, Random
• 1 Glucose, serum
• 1 Glucose, urine
• 1 Glucose 6 Phospate Deshydrogenase (G6PD)
• 1 Glucose tolerance test (OGTT)
• 1 Glutamic Acid Decarboxylase Antibodies (GAD Abs/anti GAD)
• 1 Glycomark
• 1 GM-CSF [OTI8G5]
• 1 Gomori Elastine Trichrome
• 1 Gram
• 1 Gram stain
• 1 Gram stain - Aspirate
• 1 Gram stain - CSF
• 1 Gram stain - Organism
• 1 Granzyme B [11F1]
• 1 Granzyme B [D6E9W]
• 1 Grass-mix (RAST (IgE), Dactylis glomerata, Festuca elatior, Lolium perenne, Phleum pratense, Pa pratensis)
• 1 Grass-mix (with Dactylis glomerata, Festuca elatior, Lolium perenne, Phleum pratense, Poa pratensis) to determine IgE- IgG- IgG4
• 1 Grass mix (g1-g2-g3-g4-g5-g6-g8-g9-g10) IgE
• 1 Grass specific (gx1) IgE
• 1 Grass specific (gx1) IgG4
• 1 Gross Examination
• 1 Growth Hormone (HGH)
• 2 H&E&safranin (HES) stain, FFPE
• 1 H&E&safranin (HES) stain, Prisma, preclinical
• 2 H&E stain, FFPE
• 1 H&E stain, FFPE preclinical
• 2 H&E stain, frozen
• 1 H&E staining & digitalization
• 2 H-score by HALO Software or ISH scoring
• 2 H-score by VISIOPHARM Software or ISH scoring
• 1 H. Pylori [SP48]
• 1 H3K27me3 
• 1 Haptoglobin
• 1 HbA1c (Glycated Hemoglobin)
• 1 HE
• 1 Helicobacter Pylori (H Pylori) IgG
• 1 Helix F3L final report
• 1 Helix F3L protocol
• 1 Helix F3L result
• 1 Helix F3M final report
• 1 Helix F3M protocol
• 1 Helix F3M result
• 1 Helix F6A final report
• 1 Helix F6A protocol
• 1 Helix F6A result
• 1 Helix F6A workup
• 1 Helix F6C final report
• 1 Helix F6C protocol
• 1 Helix F6C result
• 1 Helix F6C workup
• 1 Helix F7L final report
• 1 Helix F7L protocol
• 1 Helix F7L result
• 1 Helix F7L workup
• 1 Helix F55 final protocol
• 1 Helix F55 protocol
• 1 Helix F55 result
• 1 Helix F55 workup
• 1 Helix F75 final report
• 1 Helix F75 protocol
• 1 Helix F75 result
• 1 Helix F75 workup
• 1 Helix Fac final report
• 1 Helix Fac protocol
• 1 Helix Fac result
• 1 Helix Fac workup
• 1 Helix Fad final report
• 1 Helix Fad protocol
• 1 Helix Fad result
• 1 Helix Fad workup
• 1 Helix probe
• 1 Helix status
• 1 Hemaglutination Inhibition (HAI)
• 1 Hemaglutination Inhibition (HAI), Antigenic Match, Antigenic Typing with 2 reference sera, min batch size 12
• 1 Hemaglutination Inhibition (HAI), Antigenic Match, Antigenic Typing with 2 reference sera, min batch size 37
• 1 Hemaglutination Inhibition (HAI), Antigenic Match, Virus Activity, min batch size 12
• 1 Hemaglutination Inhibition (HAI), Antigenic Match, Virus Activity, min batch size 72
• 1 Hemaglutination Inhibition (HAI), H5N1
• 1 Hemaglutination Inhibition (HAI), Influenza
• 1 Hemaglutination Inhibition (HAI), Treponema Pallidum (TPHA or Syphylis)
• 1 Hematocrit (HCT)
• 1 Hematological Malignancies
• 1 Hematological Malignancies (Ganglion), FISH
• 1 Hematological Malignancies Karyotyping
• 1 Hematology panel
• 1 Hemoglobin (faecal occult blood)
• 1 Hemoglobin (HGB), electrophoresis
• 1 Hemoglobin (HGB), fecal occult blood
• 1 Hemoglobin (HGB), hematology panel
• 1 Hemoglobin (HGB), urine
• 1 Hemosiderin, urine
• 1 Heparin, unfractionated
• 1 Heparin induced platelet Ab
• 1 Hepatic alkaline phosphatase (ALP)
• 1 Hepatitis A (HAV) antibody, IgG
• 1 Hepatitis A (HAV) antibody, IgM
• 1 Hepatitis A (HAV) total (IgM, IgG)
• 1 Hepatitis B (HBV), High-sensitive, batch size 11-21
• 1 Hepatitis B (HBV), High-sensitive, batch size < 11
• 1 Hepatitis B (HBV), High-sensitive, batch size > 21
• 1 Hepatitis B (HBV), Resistance
• 1 Hepatitis B (HBV), viral load
• 1 Hepatitis B (HBV) Antibody (Core IgG) (Anti-HBc IgG)
• 1 Hepatitis B (HBV) Antibody (Core IgM) (Anti-HBc IgM)
• 1 Hepatitis B (HBV) core-related antigen (HBcrAg), batch size 11-21
• 1 Hepatitis B (HBV) core-related antigen (HBcrAg), batch size <11
• 1 Hepatitis B (HBV) core-related antigen (HBcrAg), batch size >21
• 1 Hepatitis B (HBV) core-related antigen (HBcrAg), Lumipulse, batch size 11-21
• 1 Hepatitis B (HBV) core-related antigen (HBcrAg), Lumipulse, batch size <11
• 1 Hepatitis B (HBV) core-related antigen (HBcrAg), Lumipulse, batch size >21
• 1 Hepatitis B (HBV) core antibody (total) (anti-HBc)
• 1 Hepatitis B (HBV) DNA
• 1 Hepatitis B (HBV) DNA (quantitative)
• 1 Hepatitis B (HBV) DNA/RNA UDS (1 fragment), batch size 11-21
• 1 Hepatitis B (HBV) DNA/RNA UDS (1 fragment), batch size <11
• 1 Hepatitis B (HBV) DNA/RNA UDS (1 fragment), batch size >21
• 1 Hepatitis B (HBV) DNA/RNA UDS (2 fragments, non-pooled), batch size 11-21
• 1 Hepatitis B (HBV) DNA/RNA UDS (2 fragments, non-pooled), batch size <11
• 1 Hepatitis B (HBV) DNA/RNA UDS (2 fragments, non-pooled), batch size >21
• 1 Hepatitis B (HBV) DNA/RNA UDS (2 fragments, pooled), batch size 11-21
• 1 Hepatitis B (HBV) DNA/RNA UDS (2 fragments, pooled), batch size <11
• 1 Hepatitis B (HBV) DNA/RNA UDS (2 fragments, pooled), batch size >21
• 1 Hepatitis B (HBV) DNA/RNA UDS (3 fragments, pooled), batch size 11-21
• 1 Hepatitis B (HBV) DNA/RNA UDS (3 fragments, pooled), batch size <11
• 1 Hepatitis B (HBV) DNA/RNA UDS (3 fragments, pooled), batch size >21
• 1 Hepatitis B (HBV) DNA ddPCR (high-sensitive), 2 replicates, batch size 11-21
• 1 Hepatitis B (HBV) DNA ddPCR (high-sensitive), 2 replicates, batch size <11
• 1 Hepatitis B (HBV) DNA ddPCR (high-sensitive), 2 replicates, batch size >21
• 1 Hepatitis B (HBV) DNA quantification, batch size <21
• 1 Hepatitis B (HBV) DNA quantification, batch size >21
• 1 Hepatitis B (HBV) RNA (quantitative)
• 1 Hepatitis B (HBV) RNA ddPCR 2 replicates, batch size 11-21
• 1 Hepatitis B (HBV) RNA ddPCR 2 replicates, batch size <11
• 1 Hepatitis B (HBV) RNA ddPCR 2 replicates, batch size >21
• 1 Hepatitis B (HBV) RNA qRT-PCR high-sensitive assay, batch size 11-21
• 1 Hepatitis B (HBV) RNA qRT-PCR high-sensitive assay, batch size <11
• 1 Hepatitis B (HBV) RNA qRT-PCR high-sensitive assay, batch size >21
• 1 Hepatitis B (HBV) RNA quantitative RT-qPCR, batch size 11-21
• 1 Hepatitis B (HBV) RNA quantitative RT-qPCR, batch size <11
• 1 Hepatitis B (HBV) RNA quantitative RT-qPCR, batch size >21
• 1 Hepatitis B (HBV) RNA S/RT UDS, batch size 11-21
• 1 Hepatitis B (HBV) RNA S/RT UDS, batch size <11
• 1 Hepatitis B (HBV) RNA S/RT UDS, batch size >21
• 1 Hepatitis B (HBV) RNA X-gene UDS, batch size 11-21
• 1 Hepatitis B (HBV) RNA X-gene UDS, batch size <11
• 1 Hepatitis B (HBV) RNA X-gene UDS, batch size >21
• 1 Hepatitis B (HBV) Surface Antibody (Anti-HBs)
• 1 Hepatitis B (HBV) Surface Antigen (HBs Ag)
• 1 Hepatitis B (HBV) Surface Antigen (HBs Ag), quantitative
• 1 Hepatitis B e (HBV) Antibody (Anti-HBe qualitative)
• 1 Hepatitis B e (HBV) Antigen (HBe Ag)
• 1 Hepatitis C (HCV)
• 1 Hepatitis C (HCV), resistance
• 1 Hepatitis C (HCV), viral load
• 1 Hepatitis C (HCV) Antibody
• 1 Hepatitis C (HCV) confirmation (immunoblot)
• 1 Hepatitis C (HCV) genotype 1b
• 1 Hepatitis C (HCV) RNA (qual.)
• 1 Hepatitis C (HCV) RNA (quantitative)
• 1 Hepatitis D (HDV), anti-HDV total
• 1 Hepatitis D (HDV) DNA/RNA UDS (1 fragment), batch size 11-21
• 1 Hepatitis D (HDV) DNA/RNA UDS (1 fragment), batch size <11
• 1 Hepatitis D (HDV) DNA/RNA UDS (1 fragment), batch size >21
• 1 Hepatitis D (HDV) DNA/RNA UDS (2 fragments, non-pooled), batch size 11-21
• 1 Hepatitis D (HDV) DNA/RNA UDS (2 fragments, non-pooled), batch size <11
• 1 Hepatitis D (HDV) DNA/RNA UDS (2 fragments, non-pooled), batch size >21
• 1 Hepatitis D (HDV) DNA/RNA UDS (2 fragments, pooled), batch size 11-21
• 1 Hepatitis D (HDV) DNA/RNA UDS (2 fragments, pooled), batch size <11
• 1 Hepatitis D (HDV) DNA/RNA UDS (2 fragments, pooled), batch size >21
• 1 Hepatitis D (HDV) DNA/RNA UDS (3 fragments, pooled), batch size 11-21
• 1 Hepatitis D (HDV) DNA/RNA UDS (3 fragments, pooled), batch size <11
• 1 Hepatitis D (HDV) DNA/RNA UDS (3 fragments, pooled), batch size >21
• 1 Hepatitis D (HDV) RNA qPCR (manual extraction), batch size 11-21
• 1 Hepatitis D (HDV) RNA qPCR (manual extraction), batch size <11
• 1 Hepatitis D (HDV) RNA qPCR (manual extraction), batch size >21
• 1 Hepatitis E (HEV), IgG (anti-HEV IgG)
• 1 Hepatitis E (HEV), IgM (anti-HEV IgM)
• 1 HER2
• 1 HER2 [4B5]
• 1 HER3
• 1 HercepTest (HER-2) [DG44]
• 1 Herpes Simplex Virus (HSV), Culture
• 1 Herpes Simplex Virus (HSV) IgG
• 1 Herpes Simplex Virus (HSV) IgG (anti-HSV IgG)
• 1 Herpes Simplex Virus (HSV) IgM (anti-HSV IgM)
• 1 Herpes Simplex Virus (HSV) PCR
• 1 Herpes Simplex Virus (HSV) type 1 and 2 IgG (anti-HSV IgG)
• 1 Herpes Simplex Virus (HSV) type 1 IgG (anti-HSV IgG)
• 1 Herpes Simplex Virus (HSV) type 2 IgG (anti-HSV IgG)
• 1 Herpes Virus Type 6 (HHV-6), viral load
• 1 Herpes Virus Type 8 (HHV-8), viral load
• 1 HES
• 1 High Density Lipoprotein (HDL) Cholesterol
• 1 Histamine, plasma
• 1 Histological examination by pathologist
• 1 HIS [EPR20547] (HIS tag)
• 1 HLA-DR [LN3]
• 1 HLA-DR [TAL 1B5]
• 1 Homocysteine
• 1 Homovanillic Acid (HVA)
• 1 HPGD [EPR14332]
• 1 HPIV3 virus neutralization assay, min batch size 35
• 1 HuIgG [EPR4421]
• 1 Human anti-murine antibodies (HAMA)
• 1 Human Chorionic Gonadotropin (hCG), serum
• 1 Human Chorionic Gonadotropin (hCG), urine
• 1 Human Chorionic Gonadotropin beta (beta-hCG), quantitative
• 1 Human Immunodeficiency Virus (HIV)
• 1 Human Immunodeficiency Virus (HIV) genotyping (Protease and RT)
• 1 Human Immunodeficiency Virus (HIV) I and II, anti-HIV confirmation blot outcomes
• 1 Human Immunodeficiency Virus (HIV) I and II Antibody, Rapid
• 1 Human Immunodeficiency Virus (HIV) P24 antigen (anti-p24)
• 1 Human Immunodeficiency Virus (HIV) resistance
• 1 Human Immunodeficiency Virus I (HIV) genotyping (proviral DNA)
• 1 Human Immunodeficiency Virus I (HIV-1 DNA), proviral DNA
• 1 Human Immunodeficiency Virus I (HIV-1 RNA), viral load
• 1 Human Immunodeficiency Virus I (HIV-I), RNA
• 1 Human Immunodeficiency Virus I/II (HIV I/II) antibody (HIV Ag/Ab)
• 1 Human Immunodeficiency Virus I/II (HIV I/II) antibody, cerebrospinal fluid (CSF)
• 1 Human Immunodeficiency Virus I antibody (anti-HIV-1), IEA
• 1 Human Immunodeficiency Virus I antibody (anti-HIV-1), western blot
• 1 Human Immunodeficiency Virus II (HIV-2), confirmation
• 1 Human leukocyte antigens (HLA) class I
• 1 Human leukocyte antigens (HLA) class II
• 1 Human metapneumovirus (HMPV), HMPV A and HMPV B viruses neutralization assay, non-focused, min batch size 35
• 1 Human metapneumovirus (HMPV), HMPV A and HMPV B virus neutralization assay, focused on HMPV A subtype, min batch size 35
• 1 Human metapneumovirus (HMPV), HMPV A and HMPV B virus neutralization assay, focused on HMPV B subtype, min batch size 35
• 1 Human multi-tissue slide sourcing
• 1 Human papilloma virus (HPV), high risk screen (HPV genotyping)
• 1 Human papilloma virus (HPV), high risk screen (HPV screening)
• 1 Human papilloma virus (HPV), QIAscreen
• 1 Human papilloma virus (HPV) mRNA
• 1 Human papilloma virus (HPV) mRNA HPV16, 18/45 reflex testing
• 1 Human respiratory syncytial virus type A/B (HRSV-A/B), F-gene UDS (1 fragment), batch size 11-21
• 1 Human respiratory syncytial virus type A/B (HRSV-A/B), F-gene UDS (1 fragment), batch size <11
• 1 Human respiratory syncytial virus type A/B (HRSV-A/B), F-gene UDS (1 fragment), batch size >21
• 1 Human respiratory syncytial virus type A/B (HRSV-A/B), F-gene UDS (2 fragments, non-pooled), batch size 11-21
• 1 Human respiratory syncytial virus type A/B (HRSV-A/B), F-gene UDS (2 fragments, non-pooled), batch size <11
• 1 Human respiratory syncytial virus type A/B (HRSV-A/B), F-gene UDS (2 fragments, non-pooled), batch size >21
• 1 Human respiratory syncytial virus type A/B (HRSV-A/B), F-gene UDS (2 fragments, pooled), batch size 11-21
• 1 Human respiratory syncytial virus type A/B (HRSV-A/B), F-gene UDS (2 fragments, pooled), batch size <11
• 1 Human respiratory syncytial virus type A/B (HRSV-A/B), F-gene UDS (2 fragments, pooled), batch size >21
• 1 Human respiratory syncytial virus type A/B (HRSV-A/B), RT-qPCR, excl RNAse P qPCR, batch size 11-21
• 1 Human respiratory syncytial virus type A/B (HRSV-A/B), RT-qPCR, excl RNAse P qPCR, batch size <11
• 1 Human respiratory syncytial virus type A/B (HRSV-A/B), RT-qPCR, excl RNAse P qPCR, batch size >21
• 1 Human respiratory syncytial virus type A/B (HRSV-A/B), RT-qPCR, excl RNAse P qPCR, full plates
• 1 Human respiratory syncytial virus type A/B (HRSV-A/B), RT-qPCR, incl RNAse P qPCR, batch size 11-20
• 1 Human respiratory syncytial virus type A/B (HRSV-A/B), RT-qPCR, incl RNAse P qPCR, batch size <10/run
• 1 Human respiratory syncytial virus type A/B (HRSV-A/B), RT-qPCR, incl RNAse P qPCR, batch size >21
• 1 Human respiratory syncytial virus type A/B (HRSV-A/B), RT-qPCR, incl RNAse P qPCR, full plates
• 1 Human rhinovirus (HRV), titration, TCID50
• 1 Human rhinovirus (HRV), ViroSpot reduction assay
• 1 Human rhinovirus (HRV), virus stock generation from swab
• 1 Human T-cell leukemia-lymphoma virus I/II (HTLV-I/II)
• 1 Human T-lymphotropic virus type (HTLV) I & II (anti-HTLV I/II)
• 1 Human T-lymphotropic virus type (HTLV) I & II, confirmation
• 1 Human tissue block sourcing with cession
• 1 Human tissue block sourcing without cession
• 1 Human tissue slide sourcing with cession (3µm)
• 1 Human tissue slide sourcing without cession (3µm)
• 1 Hyaluronic Acid (ELF panel)
• 1 Hydroxyproline, Urine
• 1 Identifying the area to punch
• 1 IDO [D5J4E]
• 1 IFNγ [EPR21704]
• 1 IGF B3 Protein (IGFBP-3)
• 1 IHC labelling (amplification kit) for fluorescence IHC
• 1 IHC labelling (amplification kit for chromogenic IHC)
• 1 IHC labelling (automated protocol) for fluorescence IHC
• 1 IHC labelling (automated protocol for chromogenic IHC)
• 1 IHC labelling (automated protocol for chromogenic IHC), preclinical cases
• 1 IHC labelling (automated protocol for fluorescence IHC), preclinical cases
• 1 IHC labelling (manual protocol)
• 1 IHC Labelling, Automated
• 1 IHC labelling on megablock (non-automated protocol)
• 1 IHC Stain
• 1 IHC staining : 2plex chromogeny
• 1 IHC staining: 2plex with DAPI
• 1 IHC staining: 2plex with DAPI, preclinical cases
• 1 IHC staining: 3plex with DAPI
• 1 IHC staining: 3plex with DAPI, preclinical cases
• 1 IHC staining: 4plex with DAPI
• 1 IHC staining: 4plex with DAPI, preclinical cases
• 1 IHC staining: 5plex with DAPI
• 1 IHC staining: 5plex with DAPI, preclinical cases
• 1 IHC staining: 6plex with DAPI
• 1 IHC staining: 6plex with DAPI, preclinical cases
• 1 IL-1a
• 1 IL-1alpha
• 1 IL-1b [OTI3E1]
• 1 IL-1RAP
• 1 IL-10
• 1 IL-13
• 1 IL-17
• 1 IL-22
• 1 IL-23 [HLT2736]
• 1 IL-33 [1061A]
• 1 IL-34 [OTI5E1]
• 1 IL1RAP
• 1 Image alignment with Visiopharm
• 2 Image deconvolution (in case of multispectral)
• 1 Immune repertoire sequencing, batch size 1
• 1 Immune repertoire sequencing, batch size 2
• 1 Immune repertoire sequencing, batch size 3
• 1 Immune repertoire sequencing, batch size 4
• 1 Immune repertoire sequencing, batch size 5
• 1 Immune repertoire sequencing, batch size 6
• 1 Immune repertoire sequencing, batch size 7
• 1 Immune repertoire sequencing, batch size 8
• 1 Immune repertoire sequencing, batch size 9
• 1 Immune repertoire sequencing, batch size 10
• 1 Immune repertoire sequencing, batch size 11
• 1 Immune repertoire sequencing, batch size 12
• 1 Immune repertoire sequencing, batch size 24
• 1 Immune repertoire sequencing R&D, batch size 1
• 1 Immune repertoire sequencing R&D, batch size 2
• 1 Immune repertoire sequencing R&D, batch size 3
• 1 Immune repertoire sequencing R&D, batch size 4
• 1 Immune repertoire sequencing R&D, batch size 5
• 1 Immune repertoire sequencing R&D, batch size 6
• 1 Immune repertoire sequencing R&D, batch size 7
• 1 Immune repertoire sequencing R&D, batch size 8
• 1 Immune repertoire sequencing R&D, batch size 9
• 1 Immune repertoire sequencing R&D, batch size 10
• 1 Immune repertoire sequencing R&D, batch size 11
• 1 Immune repertoire sequencing R&D, batch size 12
• 1 Immune repertoire sequencing R&D, batch size 24
• 1 Immunis serotyping assay, batch size 5-10
• 1 Immunis serotyping assay, batch size 11-21
• 1 Immunis serotyping assay, batch size <5
• 1 Immunis serotyping assay, batch size >21
• 1 Immunoglobulin IgA
• 1 Immunoglobulin IgA, immunofluorescence
• 1 Immunoglobulin IgA, rheumatoid factor
• 1 Immunoglobulin IgA, Total
• 1 Immunoglobulin IgD
• 1 Immunoglobulin IgE
• 1 Immunoglobulin IgE, mix of pneunoallergens
• 1 Immunoglobulin IgE, peanut-specific
• 1 Immunoglobulin IgE, specific antibodies
• 1 Immunoglobulin IgE, Total
• 1 Immunoglobulin IgE to rArah1 - h2 - h3 - h6 - h8 and h9, peanut-specific
• 1 Immunoglobulin IgE to rArah1, peanut-specific
• 1 Immunoglobulin IgE to rArah2, peanut-specific
• 1 Immunoglobulin IgE to rArah3, peanut-specific
• 1 Immunoglobulin IgE to rArah6, peanut-specific
• 1 Immunoglobulin IgE to rArah8, peanut-specific
• 1 Immunoglobulin IgE to rArah9, peanut-specific
• 1 Immunoglobulin IgG
• 1 Immunoglobulin IgG, quantitative
• 1 Immunoglobulin IgG, urine
• 1 Immunoglobulin IgG1
• 1 Immunoglobulin IgG1-4
• 1 Immunoglobulin IgG2
• 1 Immunoglobulin IgG3
• 1 Immunoglobulin IgG4
• 1 Immunoglobulin IgG subclasses
• 1 Immunoglobulin IgM
• 1 Immunoglobulin IgM, rheumatoid factor
• 1 Immunoglubine IgG1
• 1 Immunoglubine IgG2
• 1 Immunoglubine IgG3
• 1 Immunoglubine IgG4
• 1 Immunoglubine IgG4, peanut-specific
• 1 Immunophenotyping panel
• 2 Indexing tissue microarray (TMA) per slide
• 1 Influenza, Culture
• 1 Influenza, NA-Star® neuraminidase inhibitor resistance phenotyping assay
• 1 Influenza, NA-Star® neuraminidase inhibitor resistance phenotyping assay, min batch size 25
• 1 Influenza A, qPCR
• 1 Influenza A, Single Round PCR Amplification
• 1 Influenza A/B, PCR, qualitative
• 1 Influenza A/B, PCR, quantitative
• 1 Influenza A/B, Single Round PCR Amplification
• 1 Influenza A and B, Nested PCR Amplification
• 1 Influenza A and B virus detection NP-TMB read out, by ELISA
• 1 Influenza A subtype, ViroSpot reduction assay, min batch size 25
• 1 Influenza A subtyping (H1N1), qPCR
• 1 Influenza A subtyping (H3N2), qPCR
• 1 Influenza B, qPCR
• 1 Influenza B subtype, ViroSpot reduction assay, min batch size 25
• 1 Influenza B subtyping (Victoria Lineage), qPCR
• 1 Influenza B subtyping (Yamagata Lineage), qPCR
• 1 Influenza from swab material in MDCK cell lines, culture
• 1 Influenza in embryonated chicken eggs, culture
• 1 Influenza virus microneutralization (MN)
• 1 Influenza virus neuraminidase inhibition antibody titers, ELLA
• 1 Influenza 
• 1 Influenza Type A antibodies
• 1 Influenza Type B antibodies
• 1 Inhibin A
• 1 Inhibin B
• 1 Inhitor of matrix metalloproteinase 1 (TIMP-1), ELF panel
• 1 INSM1
• 1 Insulin
• 1 Insulin, Random
• 1 Insulin, Total
• 1 Insulin-like growth factor 1 (IGF-1)
• 1 Insulin-like growth factor 2 (IGF-2)
• 1 Insulinoma-associated Antigen 2/ Tyrosine Phosphatase (anti-IA2) Antibodies
• 1 Integrase
• 1 Interferon-gamma (IFN-y)
• 1 Interferon-gamma (IFN-y) / granzyme-B DCE using Cellular Technology Limited (CTL) kits, min batch size 25
• 1 Interferon-gamma (IFN-y) using cellular technology limited (CTL) kits, ELISpot, min batch size 25
• 1 Interleukin-1 beta (IL-1b)
• 1 Interleukin-6 (IL-6)
• 1 Interleukin-28 beta (IL-28b)
• 1 Interleukin 28Bb genotyping (rs12979860)
• 1 In vitro Transcription, RiboMAX Large Scale RNA Production System
• 1 In vitro Transcription, RiboMAX Large Scale RNA Production System, min batch size 10
• 1 Iron
• 1 Iron, Total (TIBC)
• 1 Iron, Unbounded (UIBC)
• 1 Isoniazid (INH)
• 1 JAK2 V617F
• 1 Kanamycin
• 1 Kappa
• 1 Kappa (%)
• 1 Kappa/lambda ratio
• 1 Kappa/lambda ratio, conclusion
• 1 Kappa and/or lambda, free light chains (FLC)
• 1 Kappa free light chains (FLC)
• 1 Kappa free light chains (FLC), exploratory
• 1 Kappa free light chains (FLC), secondary/CLIA
• 1 Ketones, urine
• 1 Ki-67 [30-9]
• 1 Ki-67 [B56]
• 1 Ki-67 [MiB-1]
• 1 Ki-67/Granzyme B/CD8
• 1 KL-6
• 1 Kluver Barrera (Luxol Fast Blue)
• 1 Lactate Dehydrogenase (LDH)
• 1 Lactate Dehydrogenase (LDH), oxidized
• 1 Lactic Acid (Lactate)
• 1 LAG-3 [D2G4O]
• 1 Lambda (%)
• 1 Lambda free light chain (FLC)
• 1 Lambda free light chains (FLC), secondary/CLIA
• 1 Langerin/CD1a
• 1 L CAR exploratory panel, blood
• 1 L CAR exploratory panel, bone marrow
• 1 L CAR impurities panel, bone marrow
• 1 L CAR impurity, bone marrow
• 1 L CAR impurity panel
• 1 L CAR impurity panel, blood
• 1 L CAR PK panel, blood
• 1 L CAR PK panel, bone marrow
• 1 LDL cholesterol (measured)
• 1 LDL Cholesterol, Oxydized
• 1 Legionella virus, serum
• 1 Leptin
• 1 Leukocyte, urine
• 1 Leukocytes (bone marrow)
• 1 LIF [IMG39N7D10]
• 1 Lipase
• 1 Lipid Profile (Cholesterol, LDL, HDL, Triglycerides)
• 1 Lipoprotein A (Lp(a))
• 1 Lipoproteins (Lp)
• 1 Liquid biopsy: Bladder somatic panel (FGFR2, FGFR3, ERBB2, KRAS, HRAS, BRAF, AKT1)
• 1 Liquid biopsy: BRAF, KRAS and NRAS (NGS)
• 1 Liquid biopsy: BRAF, NRAS and KIT (NGS)
• 1 Liquid biopsy: Cholangiocarcinoma panel (IDH1,KRAS,BRAF,ERBB2)
• 1 Liquid biopsy: EGFR, KRAS, BRAF, HER2, MET, STK11, TP53 and KEAP1 (NGS)
• 1 Liquid biopsy: EGFR, study exons 18-21 (NGS)
• 1 Liquid biopsy: EGFR Rapid (42 variants/PCR)
• 1 Liquid biopsy: ESR1
• 1 Liquid biopsy: KRAS, NRAS, BRAF, ERBB2, POLE and POLD1 (NGS)
• 1 Liquid biopsy: KRAS and NRAS (NGS)
• 1 Liquid biopsy: OncoSign ctDNA (45 genes) (synonym: somatic NGS cancer PANEL)
• 1 Liquid biopsy: Somatic BRCA1 and BRCA2 (NGS)
• 1 Liquid biopsy: Somatic breast cancer panel (AKT1, BRCA1, BRCA2, ERBB2, ESR1, PIK3CA)
• 1 Liquid biopsy: Somatic pancreas cancer panel (BRCA1/2,KRAS)
• 1 Lithium
• 1 Liver kidney microsome type 1 antibody (anti-LKM1)
• 1 Long-read sequencing, Oxford Nanopore, batch size 12
• 1 Long-read sequencing, Oxford Nanopore, batch size 24
• 1 Long-read sequencing R&D, Oxford Nanopore, batch size 12
• 1 Long-read sequencing R&D, Oxford Nanopore, batch size 24
• 1 Lupus Anticoagulant
• 1 Luteinizing Hormone (LH)
• 1 Lymphocyte panel
• 1 Lymphocyte panel, bone marrow
• 1 Lymphocyte panel, without natural killer (NK) cells
• 1 Magnesium, serum
• 1 Magnesium, urine
• 1 Malaria, PCR
• 1 Malaria, smear
• 1 Malaria antigen
• 1 Malaria IgG
• 1 Manufacturing of Specificity Control Block : cell spots (+) & (-)
• 1 MASH1 [EPR19592]
• 1 Masson's Trichrome blue
• 1 Masson's Trichrome blue (Masson's)
• 1 Masson's Trichrome green
• 1 Masson's Trichrome green congelee
• 1 Masson's Trichrome MMA
• 2 Masson trichrome staining
• 1 Masson trichrome staining, preclinical
• 1 Mayaro (MAYV) IgG (quantitative)
• 1 MBOAT (rs641738) polymorphysm
• 1 MCP-1/CCL2
• 1 Mean corpuscular hemoglobin (MCH)
• 1 Mean corpuscular hemoglobin concentration (MCHC)
• 1 Measles (Rubella) IgG and IgM
• 1 Measles Rubeola Virus IgG Ab
• 1 MECP2 gene (Rett disease)
• 1 MEK-1 [D2R10]
• 1 Met Ex14 skipping
• 1 Methadone
• 1 Methadone, Urine
• 1 Methicillin-resistant Staphylococcus aureus (MRSA)
• 1 Methylmalonic acid (MMA) 
• 1 MGG
• 1 MGG stain
• 1 MGIT culture
• 1 Microalbumin
• 1 Microalbumin, urine
• 1 Microsatellite instability (MSI) (MSH2, MLH1, MSH6 & PMS2)
• 1 Microsatellite instability (MSI), tumor tissue
• 1 Microsatellite instability (MSI by PCR)
• 1 Mismatch repair (MMR) status
• 1 MLH-1 [ES05]
• 1 MLH1
• 1 MMY BL
• 1 Mold - Alternaria alternata (m6)
• 1 Mold - Aspergillus fumigatus (m3), IgE
• 1 Mold - Cladosporium herbarum (m2)
• 1 Mold - Penicillium notatum (m1)
• 1 Molluscum contagiosum virus (MCV)
• 1 Monocyte panel, bone marrow
• 1 Monocytes and dentritic cells (DC) panel
• 2 MOVAT
• 1 Movat Pentachrome
• 1 mPGES-1/PTGES
• 1 MRD: AML1-ETO (RUNX1-RUNX1T1)
• 1 MRD: CBFβ-MYH11
• 1 MSH2
• 1 MSH2 [FE11]
• 1 MSH6
• 1 MSH6 [EP49]
• 1 MTB culture (liquid) (tuberculosis)
• 1 Muc5ac [45M1]
• 1 Muc5b [4A10-H2]
• 1 Multiple myeloma (MM) PGB38 panel
• 1 Multiple myeloma (MM) PGB38 panel, bone marrow
• 1 Multiple myeloma minimal residual disease panel (MM MRD) (EuroFLow or other validated panel)
• 1 Multiplex, IFN-γ, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, TNF-α
• 1 Multiplex, IL-1β, IL-2, IL-4, IL-6, IL-8, TNF-α
• 1 Mumps virus IgG
• 1 Mumps virus IgM
• 1 Muscle-specific Kinase (MuSK)
• 1 Mycobacterium tuberculosis (MTB)
• 1 Mycobacterium tuberculosis (MTB) , culture (MGIT)
• 1 Mycobacterium Tuberculosis (MTB), Identification
• 1 Mycophenolate
• 1 Mycoplasma, serology
• 1 MYD88
• 1 Myelogram (bone marrow cellular count)
• 1 Myeloperoxidase
• 1 Myoglobin, serum
• 1 Myoglobin, urine
• 1 N-acetyl-beta-glucosaminidase (NAG), Urine
• 1 N-terminal propeptide type 1 procollagen (P1NP)
• 1 N-terminal propeptide type 2 procollagen (P2NP)
• 1 Nab confirmatory batch size 10
• 1 Nab screening, batch size >25
• 2 NanoString analysis
• 1 Nasopharyngeal culture
• 1 Natural killer (NK) gamma-delta-T cell panel, blood
• 1 Natural killer (NK) gamma-delta-T cell panel, blood (tube 1 only)
• 1 Natural killer (NK) gamma-delta-T cell panel, blood (tube 4 only)
• 1 Natural killer (NK) gamma-delta-T cell panel, PBMC
• 1 NCR1 (Nkp46)
• 1 NCR1 (Nkp46) [EPR22403-57]
• 1 Nectin-1 [6F8]
• 1 Nectin-4 [EPR15613-68]
• 1 Negative amplification (1 PCR fragments)
• 1 Negative amplification (2 PCR fragments)
• 1 Negative amplification (3 PCR fragments)
• 1 Negative amplification (4 PCR fragments)
• 1 Negative amplification (5 PCR fragments)
• 1 Negative amplification (6 PCR fragments)
• 1 Negative amplification (7 PCR fragments)
• 1 Negative amplification (8 PCR fragments)
• 1 Neisseria gonorrhae, culture
• 1 Neisseria gonorrhae, PCR
• 1 Neisseria gonorrhae, serology
• 1 Nested PCR amplification influenza A/B, min batch size 12
• 1 Neutrophil elastase
• 1 NGS: Acute myeloid leukemia (AML) panel (21 genes)
• 1 NGS: BRAF, KRAS and NRAS
• 1 NGS: BRAF, NRAS and KIT
• 1 NGS: Comprehensive Fusion Genes and Exon Skipping Panel (18 genes)
• 1 NGS: EGFR, KRAS, BRAF, HER2, MET, STK11, TP53 and KEAP1
• 1 NGS: ESR1
• 1 NGS: Extended panel for hematological malignancies (176 genes)
• 1 NGS: Fusion and exon skipping detection by RNA sequencing: ALK/RET/ROS1/ERBB2/MET/NTRK1/2/3/NRG1/FGFR1/2/3/EGFR
• 1 NGS: HLA Typing Solution (ALLType™ FASTplex™ NGS v2 Assay (ThermoFisher))
• 1 NGS: HRD status and somatic BRCA1/2
• 1 NGS: KRAS and NRAS
• 1 NGS: Lymphoid panel (87 genes)
• 1 NGS: MLH1 promotor methylation (MLPA)
• 1 NGS: Multiple myeloma panel (26 genes)
• 1 NGS: Myeloma panel (74 genes)
• 1 NGS: OncoSign 600+ (638 genes)
• 1 NGS: OncoSign FFPE (45 genes)
• 1 NGS: Pan myeloid cancer panel (92 genes)
• 1 NGS: PIK3CA
• 1 NGS: Shallow-Whole Geneme Sequensing (sWGS)
• 1 NGS: Somatic bladder panel (FGFR2, FGFR3, ERBB2, KRAS, HRAS, BRAF, AKT1)
• 1 NGS: Somatic breast cancer panel (AKT1, BRCA1, BRCA2, ERBB2, ESR1, PIK3CA)
• 1 NGS: Somatic endometrial panel (TP53, POLE, BRCA1, BRCA2)
• 1 NGS: Somatic neuro panel (ATRX, BRAF, CDK4, CDK6, CDKN2A, EGFR, FGFR1/2/3, H3C3, H3F3A, HRAS, IDH1, IDH2, KRAS, MAP2K1, MET, NRAS, PDGFRA, PIK3CA, POLE, PTEN, RB1, TERT, TP53)
• 1 NGS: Somatic pancreas cancer panel (BRCA1/2,KRAS)
• 1 Nicotine
• 1 Nitrites, urine
• 1 NKp46/CD8/Granzyme B/TCRγδ
• 1 NKT1 cell panel (as intracellular cytokine panel (ICS)), BAL (bronchoalveolar lavage) fluid
• 1 NKT1 cell panel (as intracellular cytokine panel (ICS)), PBMC
• 1 Norovirus
• 1 NRAS, BRAF, KRAS genes
• 1 Nucleic acid purification, on MagNA Pure 96
• 1 Number BMMCs (aliquot 2 - dry pellet)
• 1 Number BMMCs (tube 2)
• 1 Number BMMCs (tube 3)
• 1 Number BMMCs (tube 4)
• 1 Number BMMCs (tube 5)
• 1 Number BMMCs (tube 6)
• 1 Number BMMCs (tube 7)
• 1 Number BMMCs (tube 8)
• 1 Number BMMCs (tube RST)
• 1 Number BMMCs, total
• 1 Number CD3+CD138- (aliquot 2 - DMSO/fetal bovine serum (FBS))
• 1 Number CD3+CD138- (aliquot 3 - DMSO/fetal bovine serum (FBS)
• 1 Number CD3+CD138- (DMSO/fetal bovine serum (FBS))
• 1 Number CD3+CD138- (rest, DMSO/fetal bovine serum (FBS))
• 1 Number CD3+CD138- (rest - dry pellet)
• 1 Number CD3+CD138- (RLT)
• 1 Number CD3+CD138- cells, total
• 1 Number CD3-CD138- (aliquot 2 - DMSO/fetal bovine serum (FBS))
• 1 Number CD3-CD138- (DMSO/fetal bovine serum (FBS))
• 1 Number CD3-CD138- (rest - DMSO/fetal bovine serum (FBS))
• 1 Number CD3-CD138- cells, total
• 1 Number CD138+ (aliquot 2 - DMSO/fetal bovine serum (FBS))
• 1 Number CD138+ (DMSO/fetal bovine serum (FBS))
• 1 Number CD138+ (dry pellet)
• 1 Number CD138+ (dry pellet - aliquot 2)
• 1 Number CD138+ (rest - DMSO/fetal bovine serum (FBS))
• 1 Number CD138+ (rest - dry pellet)
• 1 Number CD138+ cells, total
• 1 Number CD138+ cells for storage
• 1 Number CD138+ for FISH (aliquot 2/remainder cells)
• 1 Number CD138+ for FISH (rest)
• 1 Number CD138+ for RNA (RLT)
• 1 Number CD138- (DMSO/fetal bovine serum (FBS))
• 1 Number CD138- cells (tube 1)
• 1 Number CD138- cells (tube 2)
• 1 Number CD138- cells (tube 3)
• 1 Number CD138- cells (tube 4)
• 1 Number CD138- cells (tube 5)
• 1 Number CD138- for DNA (dry pellet)
• 1 Number CD138- for RNA (RLT)
• 1 Number cells lysed blood (DMSO/FBS) - aliquot 1
• 1 Number cells lysed blood (DMSO/FBS) - aliquot 2
• 1 Number of cryovials
• 1 Number of cryovials (isolated PBMC, dry pellet, So-hep 1)
• 1 Number of cryovials (isolated PBMC, So-citr 2)
• 1 Number of cryovials (isolated PBMC, So-citr 4)
• 1 Number of cryovials (isolated PBMC, So-citr 5)
• 1 Number of cryovials (isolated PBMC, So-hep 1)
• 1 Number of cryovials (isolated PBMC, So-hep 2)
• 1 Number WBM, total
• 1 Occult Blood, urine (RBC)
• 1 OCT block embedding - Clinical
• 1 OCT block embedding-Pre clinique
• 1 Ofloxacin (Moxifloxacin)
• 1 Oil Red O - hematox Harris frozen
• 1 Oil Red O - hematox Mayer frozen
• 1 Olanzapine
• 1 One protein
• 1 Opiates, urine
• 1 Orceine
• 1 Orosomucoid
• 1 Osmolality, serum
• 1 Osmolality, urine
• 1 Osteocalcin
• 1 Other qPCR assays
• 1 OX40
• 1 OX40 [ACT35]
• 1 OX40 [D156L]
• 1 OX40L
• 1 OX40L [D6K7R]
• 1 Oxalate
• 1 Oxycodone, urine
• 1 p16
• 1 p16 [E6H4]
• 1 p53
• 1 p53 [DO-7]
• 1 Palivizumab Competing Antibody (PCA) assay, Min batch size 25
• 1 Pan-keratin [C11]
• 1 PAN-TEAD [D3F7L]
• 1 pan-TRK [EPR17341]
• 1 PanCK [AE1/AE3]
• 1 Pancreatic amylase
• 1 Panel M1/M2 (pSTAT1/cMAF/CD68/CD163)
• 1 Pan Myeloid broad panel NGS
• 1 Paraffin block embedding (w/o decal) & vial disposal-Clinical
• 1 Paraffin block embedding (w/o decal) & vial disposal-Pre-clinical
• 1 Paraffin block embedding (with decalcification)-Clinical & Pre
• 1 Paraffin block embedding (without decalcification)-Clinical
• 1 Paraffin block embedding (without decalcification)-Pre cli
• 1 Paraffin block embedding : Cell pelets
• 1 Paraffin block embedding with trimming - Pre clinical
• 1 Paraffin MEGABLOCK embedding
• 1 Paraffin MEGABLOCK embedding (with decalcification)
• 1 Parathyroid Hormone (PTH), Intact
• 1 Partial Thromboplastin Time (PTT), Activated PTT (APTT)
• 1 Partial Thromboplastin Time (PTT), Corrected
• 1 Parvovirus B19, PCR
• 1 Parvovirus B19, serology, IgG
• 1 Parvovirus B19, serology, IgM
• 1 PAS
• 2 PAS (Periodic acid-Schiff), Alcian blue, Hematoxylin
• 1 PAS (Periodic acid-Schiff), Alcian blue, Hematoxylin (preclinical)
• 1 PAS MMA
• 1 Pathology review
• 1 Pax-5
• 1 PaxGene tube processing
• 1 PBMC concentration (fixed, So-citr 1)
• 1 PBMC concentration (fixed, So-citr 2)
• 1 PBMC concentration (fixed, So-citr 4)
• 1 PBMC concentration (fixed, So-citr 5)
• 1 PBMC concentration (fixed, So-hep 1)
• 1 PBMC concentration (fixed, So-hep 2)
• 1 PBMC concentration, dry pellets
• 1 PBMC concentration and cryovial CPT (cell prepraration tube)
• 1 PBMC Isolation (2 patients)
• 1 PBMC isolation (fixed concentration, So-citr 1)
• 1 PBMC isolation (fixed concentration, So-citr 2)
• 1 PBMC Isolation, CPT (cell prepraration tube) 8 mL, 1 CPT
• 1 PBMC Isolation, CPT (cell prepraration tube) 8 mL, 2 CPT
• 1 PBMC Isolation, CPT (cell prepraration tube) 8 mL, 3 CPT
• 1 PBMC Isolation, CPT (cell prepraration tube) 8 mL, 4 CPT
• 1 PBMC Isolation, CPT (cell prepraration tube) 8 mL, 5 CPT
• 1 PBMC isolation, CPT-8mL (cell prepraration tube)
• 1 PBMC viability (dry pellet, So-citr 1)
• 1 PBMC viability (So-citr 2)
• 1 PBMC viability (So-citr 4)
• 1 PBMC viability (So-citr 5)
• 1 PBMC viability (So-hep 1)
• 1 PBMC viability (So-hep 2)
• 1 PD-1
• 1 PD-1 [EH12.2H7]
• 1 PD-1 [NAT105]
• 1 PD-L1 (22C3 clone)
• 1 PD-L1 (28-8 clone)
• 1 PD-L1 (SP142 clone)
• 1 PD-L1 (SP263 clone)
• 1 PD-L1 in tumor cells
• 1 PD-L1 [22C3]
• 1 PD-L1 [73-10]
• 1 PD-L1 [E1L3N]
• 1 PD-L1 [SP142]
• 1 PD-L1 [SP263]
• 1 Peanut-Specific IgE Class
• 1 Perls' Roche
• 1 Pertussis Toxin, IgG
• 1 pH
• 1 Phencyclidine
• 1 Phencyclidine, Urine
• 1 Phenylalanine
• 1 Phenytoin (dilantin)
• 1 PHH3
• 1 Phosphatidylethanol (PETH, PET)
• 1 Phospho-Tau
• 1 Phosphorus (phosphate)
• 1 Phosphorus (phosphate), urine
• 1 PIK3CA
• 1 PK for biologics / biosimilar, batch size 30-180
• 1 PK for biologics / biosimilar, batch size 181-900
• 1 PK for biologics / biosimilar, batch size >900
• 1 Plasma cells (%)
• 1 Plasma cells panel
• 1 Plasminogen
• 1 Plasminogen activator inhibitor-1 (PAI)
• 1 Plasmocyte panel (CD19, CD20, CD38, CD45, CD56, CD117, CD138, kappa and lambda light chains)
• 1 Platelets (PLT)
• 1 PML-RARA fusion gene
• 1 PMS2
• 1 PMS2 [EP51]
• 1 PNPLA3 genotyping (single nucleotide polymorphism (SNP))
• 1 Poliomavirus, JC family
• 1 Poliovirus (PV)
• 1 Poliovirus (PV) (SABIN 1/2/3 strains) multiplex qPCR
• 1 Poliovirus (PV) 1,2 antibody
• 1 Poliovirus (PV) CCID50 method, min batch size 25
• 1 Poliovirus (PV) neutralization assay, min batch size 35
• 1 Positive controls, qPCR
• 1 Post-natal CGH (comparative genomic hybridization)
• 1 Potassium (K)
• 1 Potassium (K), urine
• 1 Prealbumin
• 1 Pregnancy test, serum
• 1 Pregnancy test, urine
• 1 Preparation of 5 serial tissue sections per block
• 1 Pro-C3
• 1 Pro-C6
• 1 Pro b-type natriuretic peptide (NT-proBNP)
• 1 Procalcitonin (PCT)
• 1 Procollagen III amino-terminal peptide (PIIINP), ELF panel
• 1 Progesterone
• 1 Progesterone receptor (PR)
• 1 Proinsulin
• 1 Prolactin
• 1 Propoxyphene, urine
• 1 Prostatic specific antigen (PSA), free
• 1 Prostatic specific antigen (PSA), total
• 1 Prostatic specific antigen (PSA), total and free
• 1 Protein, cerebrospinal fluid (CSF)
• 1 Protein, total
• 1 Protein, total (24h), urine
• 1 Protein, urine
• 1 Proteinase 3 Ab
• 1 Protein C, antigen (ultra-sensitive)
• 1 Protein C activity
• 1 Protein S, antigen
• 1 Protein S100
• 1 Protein S activity
• 1 Prothrombin, Fragment 1 and 2 (PF1+2)
• 1 Prothrombin Gene Variant, 2021G >A
• 1 Prothrombin Time (PT (Sec))
• 1 Prothrombin Time with INR (PT INR) 
• 1 PR [1E2]
• 1 PT fragment 1+2
• 1 PTK7 (CCK4) [D2Z1N]
• 1 Pyrazinamide (PZA) 
• 1 Pyruvic acid (pyruvate, total ketones)
• 1 Quantiferon-TB gold plus (tuberculosis)
• 1 Rapid plasma reagin (PRP)
• 1 Rate dead cells
• 1 Rate dead cells (BMMCs)
• 1 Rate of plasma cells in WBM
• 1 Reagents for cell culture maintenance or restart (per week)
• 1 Red blood cells (RBC)
• 1 Red blood cells (RBC) / Lysis
• 1 Red cell distribution width (RDW)
• 1 Renin
• 1 Renin (supine)
• 1 Rerun NGS libray preparation without sequencing step, min batch size 12
• 1 Respiratory panel (ePlex)
• 1 Respiratory synctial virus (RSV), culture in flasks
• 1 Respiratory synctial virus (RSV), fusion inhibition assay, min batch size 25
• 1 Respiratory synctial virus (RSV), microneutralization susceptibility assay
• 1 Respiratory synctial virus (RSV), ViroSpot reduction assay for antiviral compound
• 1 Respiratory synctial virus A (RSV A), qPCR
• 1 Respiratory syncytial virus (RSV), RT-PCR
• 1 Respiratory syncytial virus (RSV), swab
• 1 Respiratory syncytial virus B (RSV B), qPCR
• 1 Respiratory syncytial virus (RSV), IgG/IgM kit
• 2 Reticulin
• 1 Reticulin (proto N°2)
• 1 Reticulin, preclinical
• 1 Reticulocytes
• 1 Reticulocytes (%)
• 1 RET [EPR2871]
• 1 Rhesus D (RhD) Genotyping
• 1 Rhesus D (RhD) Phenotype (ABO/Rh type)
• 1 Rheumatoid factor
• 1 Rheumatoid factors, immunoglobuline IgA
• 1 Rheumatoid factors, immunoglobuline IgM
• 1 Rhinovirus, qPCR
• 1 Rhinovirus/enterovirus, culturing with swab material
• 1 Rhinovirus/enterovirus, ViroSpot reduction assay, focused on enterovirus
• 1 Rhinovirus/enterovirus, ViroSpot reduction assay, focused on rhinovirus
• 1 Rifampicin resistance-Mycobacteria, PCR
• 1 Rifampin (rifampicin)
• 1 Risperidone
• 1 RNA preparation (FFPE) extraction, purification and quantification
• 1 ROR1 [D6T8C]
• 1 ROR1 [ISH]
• 1 ROR2
• 1 ROS1 translocation, FISH
• 1 ROS1 [SP384]
• 1 Rotavirus (RV)
• 1 Rotavirus (RV), direct screen
• 1 Rotavirus (RV), immunochromatography
• 1 Rotavirus (RV), serology
• 1 Rotavirus (RV), serology complement fixation
• 1 Rota virus + Adenovirus + Norovirus AG
• 1 Rota virus + Adenovirus AG
• 1 Rouge Alizarine
• 1 Rouge Sirius
• 1 RSV A and RSV B virus neutralisation assay, focused on RSV A subtype, min batch size 35
• 1 RSV A and RSV B virus neutralisation assay, focused on RSV B subtype, min batch size 35
• 1 RSV A and RSV B virus neutralisation assay, min batch size 35
• 1 RSV microneutralization susceptibility assay, Min batch size 35
• 1 Rubella Virus antibody, IgG
• 1 Rubella Virus antibody, IgM
• 1 Saccharomyces cerevisiae (ASCA), IgG and IgA
• 1 Salicylate
• 1 SARS-CoV-2 (COVID-19)
• 1 SARS-CoV-2 (COVID-19) (2 pools of non-overlapping amplimers), batch size >21
• 1 SARS-CoV-2 (COVID-19), Abbott
• 1 SARS-CoV-2 (COVID-19), Bioreference
• 1 SARS-CoV-2 (COVID-19), CoviDetect mutation assay
• 1 SARS-CoV-2 (COVID-19), Lapcorp
• 1 SARS-CoV-2 (COVID-19), Mayo Clinic
• 1 SARS-CoV-2 (COVID-19), Quest, calculation
• 1 SARS-CoV-2 (COVID-19), Rapid
• 1 SARS-CoV-2 (COVID-19), viral load
• 1 SARS-CoV-2 (COVID-19) ddPCR
• 1 SARS-CoV-2 (COVID-19) IgG
• 1 SARS-CoV-2 (COVID-19) IgG and IgA
• 1 SARS-CoV-2 (COVID-19) IgM
• 1 SARS-CoV-2 (COVID-19) N-gene, qPCR
• 1 SARS-CoV-2 (COVID-19) NAAT
• 1 SARS-CoV-2 (COVID-19) NGS
• 1 SARS-CoV-2 (COVID-19) Nucleocapsid Ab
• 1 SARS-CoV-2 (COVID-19) PCR
• 1 SARS-CoV-2 (COVID-19) plaque reduction neutralization test (PRNT), min batch size 35
• 1 SARS-CoV-2 (COVID-19) plaque reduction neutralization test (PRNT), min batch size < 35
• 1 SARS-CoV-2 (COVID-19) RNA
• 1 SARS-CoV-2 (COVID-19) spike (2 pools of non-overlapping amplimers), batch size 24 (48 pools)
• 1 SARS-CoV-2 (COVID-19) spike (2 pools of non-overlapping amplimers), batch size 48 (96 pools)
• 1 SARS-CoV-2 (COVID-19) spike (2 pools of non-overlapping amplimers), batch size <24 (48 pools)
• 1 SARS-CoV-2 (COVID-19) total (IgA, IgG, IgM)
• 1 SARS-CoV-2 (COVID-19) total (IgA, IgG, IgM), N-protein
• 1 SARS-CoV-2 (COVID-19) ViroSpot reduction assay, Min batch size 25
• 1 SARS-CoV-2 (COVID-19) whole genome sequencing WGS (2 pools of non-overlapping amplimers), batch size 11-21
• 1 SARS-CoV-2 (COVID-19) whole genome sequencing WGS (2 pools of non-overlapping amplimers), batch size 12 (24 pools)
• 1 SARS-CoV-2 (COVID-19) whole genome sequencing WGS (2 pools of non-overlapping amplimers), batch size 24 (48 pools)
• 1 SARS-CoV-2 (COVID-19) whole genome sequencing WGS (2 pools of non-overlapping amplimers), batch size 48 (96 pools)
• 1 SARS-CoV-2 (COVID-19) whole genome sequencing WGS (2 pools of non-overlapping amplimers), batch size <11
• 1 SARS-CoV-related qPCR (polymerase-helicase)
• 1 SARS-CoV2 (COVID-19), IgG
• 1 SARS-CoV2 (COVID-19), IgG (Quantitative)
• 1 SARS-CoV2 (COVID-19), IgG + IgM
• 1 SARS-CoV2 (COVID-19), ViroSpot reduction assay
• 1 SCC (Squamous Cell Carcinoma)
• 1 SCN5A
• 1 Second Line
• 1 Sectioning and H&E staining
• 1 Sediment urinalysis (microscopy)
• 1 Sequencing using nested PCR technology, min batch size 10
• 1 Sequencing using single round PCR technology, min batch size 10
• 1 Serotonin
• 1 Serum amyloid A
• 1 Serum electrophoresis (sPEP)
• 1 Serum electrophoresis (sPEP) / immunofixation
• 1 Serum Free Light Chains - (kappa- lambda + ratio)
• 1 Serum immunofixation (sIF)
• 1 Serum Protein Electrophoresis (sPEP) + total protein + Immunofixation
• 1 Setting determination : Cell segmentation/threshold setting cellular density by biomarker
• 2 Setting determination : Cell segmentation threshold setting / H-Score by biomarker
• 2 Setting determination : Phenotype 2plex (per combination)
• 2 Setting determination : Phenotype 3plex (per combination)
• 2 Setting determination : Phenotype 4plex (per combination)
• 2 Setting determination : Phenotype 5plex (per combination)
• 2 Setting determination : Phenotype by HALO (per combination)
• 1 Setting determination : Segmentation/Threshold density (Visiopharm)
• 2 Setting determination : Spatial analysis (Between 2 populations)
• 2 Setting determination : Spatial analysis - Infiltration (Between 2 populations)
• 2 Setting determination : Spatial analysis - Proximity (Between 2 populations)
• 1 Setting determination : Staining area quantification (Visiopharm)
• 2 Setting determination : Staining area quantification per biomarker
• 1 Sex Hormone Binding Globulin (SHBG)
• 1 Silver (Ag)
• 1 Simplex quantification by HALO Software on Multiplex (2 targets+nuclei marker) (adding app development)
• 1 Simplex quantification by HALO Software on Multiplex (3 targets+nuclei marker) (adding app development)
• 1 Simplex quantification by HALO Software on Multiplex (4 targets+nuclei marker) (adding app development)
• 1 Simplex quantification by HALO Software on Multiplex (5 targets+nuclei marker) (adding app development)
• 1 Simplex quantification by VISIOPHARM Software on Multiplex (2 targets+nuclei marker) (adding app development)
• 1 Simplex quantification by VISIOPHARM Software on Multiplex (3 targets+nuclei marker) (adding app development)
• 1 Simplex quantification by VISIOPHARM Software on Multiplex (4 targets+nuclei marker) (adding app development)
• 1 Simplex quantification by VISIOPHARM Software on Multiplex (5 targets+nuclei marker) (adding app development)
• 1 Single Round PCR Amplification Influenza A , min batch size 12
• 1 Single Round PCR Amplification Influenza A/B, min batch size 12
• 1 Sirolimus (Rapamycin)
• 1 SIRPalpha [D6I3M]
• 1 Sjogren's syndrome antibodies
• 1 SKN1
• 1 SLCO2A1 (PGT)
• 1 SLFN11 [D8W1B]
• 1 Slide staining (minimum 400 supernatants, 12/slide)
• 1 Sodium (Na)
• 1 Sodium (Na), urine
• 1 Sourcing set-up
• 2 Spatial analysis (per pair)
• 1 SPDEF
• 1 Special megablock staining
• 1 Specific gravity, urine
• 1 Specific gravity, urine dipstick (URC)
• 1 Specific zone macro research for section
• 1 Sputum culture
• 1 Sputum culture result
• 1 Sputum macroscopy
• 1 Standard megablock staining
• 1 Stool culture + selective isolation of enteric pathogens (Yersinia-Shigella-Salmonella-aeromonas spp, EHEC) + identification of pathogens (=aerobe faces culture)
• 1 Stool culture for enteric pathogens, Yersinia-Shigella-Salmonella-Campylobacter
• 1 Streck cfDNA tube processing
• 1 Streptococcus Pneumoniae Antibody
• 1 Streptomycin
• 1 Strongyloidiasis
• 1 Sulfosalicylic acid test 
• 1 Superoxide dismutase
• 1 Surface quantification and/or staining intensity by biomarker (adding app development)
• 1 Surface quantification and/or staining intensity per marker, Visiopharm
• 1 Surgical swab culture
• 1 SYK
• 1 Syphilis (treponema pallidum), blot
• 1 Syphilis (treponema pallidum) RPR (rapid plasma reagin)
• 1 Syphilis (treponema pallidum) RPR (rapid plasma reagin), CSF
• 1 T3 (triiodothyronine)
• 1 T3 (triiodothyronine), free
• 1 T3 (triiodothyronine), reverse
• 1 T4 (thyroxine), free
• 1 T4 (thyroxine), total
• 1 Tacrolimus
• 1 Taz
• 1 TBNK and monocytes panel, 14 color panel, blood
• 1 TBNK expanded panel
• 1 TBNK panel
• 1 TBNK panel, with dilution
• 1 T cell, NK cell activation panel (TNKT ACT)
• 1 T cells Clonality
• 1 TCF4 [NCI-R159-6]
• 1 TCF4/CD123
• 1 TCF7L2
• 1 TCID50
• 1 TCL1 [1-21]
• 1 TCRgd [H-41]
• 1 TCR Vy9 [7A5]
• 1 Testosterone, Bioavailability
• 1 Testosterone, free
• 1 Testosterone, total
• 1 Tetrahydrocannabinol, Cannabinoids (THC), Cannabis, Urine
• 1 Theophyline
• 1 ThinPrep, non-gynecologic
• 1 Thinprep PAP test (PAP smear, cervix PAP)
• 1 Thrombin time (TT)
• 1 Thyroglobulin
• 1 Thyroid panel (TSH, free T3, free T4)
• 1 Thyroid Stimulating Hormone (TSH)
• 1 Thyroxine binding globulin (TBG)
• 1 Thyroxin Free
• 1 Tick-borne encephalitis, IgG
• 1 TIM-3 [D5D5R]
• 1 Timothy grass mix
• 2 Tissue Align Overlay (per sample)
• 1 Tissue block qualification
• 1 Tissue cession contracting fees
• 1 Tissue factor [E9M6T]
• 1 Tissue microarray (TMA) section
• 1 Tissue plasminogen activator
• 1 Tissue polypeptide antigen (TPA) 
• 1 Titration of echovirus 7, min batch size 25
• 1 Titration of enteroviruses (EV) on cells
• 1 Titration of human metapneumovirus A (HMPV-A) stocks on Vero cells, min batch size 25
• 1 Titration of human metapneumovirus B (HMPV-B) stocks on Vero cells, min batch size 25
• 1 Titration of human parainfluenza virus type 3 (HPIV-3) stocks on Vero cells, min batch size 25
• 1 Titration of infectious influenza virus A subtype, stocks on MDCK cells
• 1 Titration of infectious influenza virus B subtype, stocks on MDCK cells
• 1 Titration of infectious influenza viruses, stocks on MDCK cell cultures
• 1 Titration of infectious influenza virus on MDCK cell cultures with NP-ELISA readout, min batch size 25
• 1 Titration of infectious respiratory synctial virus (RSV) on adherent cells using ViroSpot immunostaining readout, min batch size 25
• 1 Titration of rhinovirus on cells, min batch size 25
• 1 Titration of SARS-CoV-2 (COVID-19) on Vero E6 cells, min batch size 25
• 1 TM6F2
• 1 TNFa [52B83]
• 1 TNFR2
• 1 TNFRSF14 [2G6-2C7]
• 1 Total antioxidant capacity (TAC)
• 1 Total Tau (protein Tau, phospho-Tau, beta amyloid)
• 1 Total volume PBMC (So-citr 2)
• 1 Total volume PBMC (So-citr 4)
• 1 Total volume PBMC (So-citr 5)
• 1 Total volume PBMC (So-hep 1)
• 1 Total volume PBMC (So-hep 2)
• 1 Toxoplasma serology, IgG
• 1 Toxoplasma serology, IgM
• 1 Toxoplasma serology, IgG and IgM
• 1 TP53
• 1 Tramsferrin, saturation coefficient
• 1 Transferrin
• 1 Transferrin, total
• 1 Treponema pallidum (syphilis), confirmation (blot)
• 1 Treponema pallidum (syphilis), serology, IgM
• 1 Treponema pallidum VDRL (syphillis, TPHA, venereal disease research laboratory (VDRL))
• 1 Trichomanas vaginalis
• 1 Tricyclic antidepressants, urine
• 1 Triglycerides
• 1 Trimming (MEGABLOCK)
• 1 TROP2 [EPR20043]
• 1 Troponin I
• 1 Troponin T
• 1 Troponin T (high sensitivity)
• 1 Tryptase
• 1 Tsub (CD4/8)
• 1 T subset CAR T panel, U CART20x22, blood (TSUB UCART20x22)
• 1 T subset CAR T panel, U CART22, blood (BL_TSUB_UCART22)
• 1 T subset memory panel (TSUB memory)
• 1 T subset panel (TSUB KiHBB B)
• 1 Tuberculosis (TB), DNA extraction
• 1 Tuberculosis (TB), rapid antigen (MTB)
• 1 Tumor microarray (TMA) block qualification (12 spots)
• 1 Tumor necrosis Factor Alpha (TNF)
• 1 Tyrosine
• 1 UCAR20x22
• 1 U CART19 cells panel
• 1 UGT1A1
• 1 UGT1A2
• 1 Ultracentrifugation
• 1 Urea
• 1 Urea, urine
• 1 Uric acid
• 1 Uric acid, urine
• 1 Urinalysis
• 1 Urinalysis (sediment)
• 1 Urine, Screen
• 1 Urine culture
• 1 Urine culture result
• 1 Urine Drug Screen (3 parameters)
• 1 Urine Drug Screen (5 parameters)
• 1 Urine Drug Screen (6 parameters)
• 1 Urine Drug Screen (7 parameters)
• 1 Urine Drug Screen (8 parameters)
• 1 Urine Drug Screen (9 parameters)
• 1 Urine Drug Screen (10 parameters)
• 1 Urine Drug Screen (11 parameters)
• 1 Urine electrophoresis (uPEP)
• 1 Urine electrophoresis (uPEP) / immunofixation
• 1 Urine electrophoresis / immunofixation
• 1 Urine immunofixation
• 1 Urobilinogen
• 1 Valproic Acid (VPA)
• 1 Vancomycin
• 1 Vanillymandelic acid (VMA)
• 1 Varicella (VZV) IgG
• 1 Varicella (VZV) IgG and IgM
• 1 Varicella (VZV) IgM
• 1 Vasopressin (ADH)
• 1 Vasopressin (ADH), plasma
• 1 Vasopressin (ADH), urine
• 1 Vbeta17 T cell subset panel, blood
• 1 Vbeta17 T cell subset panel, blood (tube 3 only)
• 1 Vbeta17 T cell subset panel, bone marrow
• 1 Vbeta17 T cell subset panel, bone marrow (tube 3 only)
• 1 Vimentin
• 1 Vimentin [1]
• 1 Vimentin [RV202]
• 1 Vimentin [V9]
• 1 Viral antibody, western blot
• 1 Viral antibody detection
• 1 Viral culture (plasma)
• 1 Viral culture (rectal swab)
• 1 Viral culture (throat swab)
• 1 ViroSpot microneutralization (MN) assay for antigenic typing of influenza virus A (INF-A), min batch size 35
• 1 ViroSpot microneutralization (MN) assay for antigenic typing of influenza virus B (INF-B), min batch size 35
• 1 ViroSpot microneutralization (MN) assay for antigenic typing of influenza viruses, min batch size 35
• 1 Virus-like particle (VLP) IgG
• 1 Virus Culture ELISA for infectious influenza A and B virus detection, min batch size 25
• 1 Virus stock generation in cell culture (general)
• 1 Virus typing using nested PCR technology and Sanger sequencing, min batch size 10
• 1 Vitamim C
• 1 Vitamin A1
• 1 Vitamin B1
• 1 Vitamin B2
• 1 Vitamin B6
• 1 Vitamin B12
• 1 Vitamin B12, active
• 1 Vitamin C
• 1 Vitamin D
• 1 Vitamin E
• 1 VKORC1
• 1 VLDL cholesterol
• 1 Von Kossa
• 1 VRK1
• 1 West Nile Virus, PCR
• 1 West Nile Virus, serology, IgG and IgM
• 1 Wet smear Gram stain with Nugent scoring and Clue cell presence/absence
• 1 White Ash specific IgE
• 1 White blood cells (WBC)
• 1 White blood cells (WBC), Leucocytes
• 1 WHO influenza virus A subunit neutralization assay, min batch size 35
• 1 WHO Influenza Virus B subunit neutralization assay, min batch size 35
• 1 WHO influenza viruses neutralization assay, min batch size 35
• 1 Whole genome sequencing (WGS) (no NAI), extracted DNA, batch size 24
• 1 Whole genome sequencing (WGS) (no NAI), extracted DNA, batch size 48
• 1 Whole genome sequencing (WGS) (no NAI), extracted DNA, batch size 96
• 1 Whole genome sequencing (WGS) (with NAI), cultured bacterial isolate, batch size 24
• 1 Whole genome sequencing (WGS) (with NAI), cultured bacterial isolate, batch size 48
• 1 Whole genome sequencing (WGS) (with NAI), cultured bacterial isolate, batch size 96
• 1 Whole respiratory syncytial virus (RSV) protein hIgG ELISA, RSV IgG/IgM kits, min batch size 25
• 1 Wholescan Fluorescence Digitization - Simplex
• 1 Wholescan Fluorescence Digitization - Simplex + DAPI
• 1 Wholescan Fluorescence Digitization - tumor microarray (TMA)
• 2 Wholescan Fluorescent Digitization - Biopsy - 2plex MOTIVE
• 2 Wholescan Fluorescent Digitization - Biopsy - 3plex MOTIVE
• 2 Wholescan Fluorescent Digitization - Biopsy - 4plex mircrosatellite instability (MSI)
• 2 Wholescan Fluorescent Digitization - Biopsy - 4plex MOTIVE
• 2 Wholescan Fluorescent Digitization - Biopsy - 5plex mircrosatellite instability (MSI)
• 2 Wholescan Fluorescent Digitization - Biopsy - 5plex MOTIVE
• 2 Wholescan Fluorescent Digitization - Biopsy - 6plex mircrosatellite instability (MSI)
• 1 WPRE
• 1 XBP-1s [143F]
• 1 YAP [EPR19812]
• 1 Yeast cells
• 1 Yellow fever virus, IgG
• 1 Ziehl Neelson stain of sputa for AFB
• 1 Zika Virus PCR
• 1 Zika Virus serology, IgG (quantitative)
• 1 Zinc
• 1 ZN smear for confirmation
• 1 β-1,3-D-glucan (BDG)